Prof. Dr. OĞUZ REŞAT SİPAHİ
Kendi kendine olmayan
atıflar/Non-self citations
Kitaplar ve textbooklardaki
atıflar/Citations in books and textbooks
1) Verma A
Infections of the nervous system: Bacterial infections. In: Bradley WG, Daroff
RB, Fenichel GM, Jankovic J (eds) Neurology in
Clinical Practice. 5th ed. PA, Elsevier 2008:1420-1456.
2) Tunkel AR, van de Beek D, Scheld
WM. Acute meningitis. In: Mandell GL, Bennett JE, Dolin R. (eds) Principles and Practice of Infectious Diseases.
7th ed. Newyork, Churchill Livingstone, Elsevier 2010:1189-1229.
3) Edwards JE JR. Candida species. In:
Mandell GL, Bennett JE, Dolin R. (eds) Principles
and Practice of Infectious Diseases. 7th ed. Newyork, Churchill
Livingstone, Elsevier 2010:3225-3240.
4) Gyssens IC. Teicoplanin. In:
Grayson ML. (ed) Kucher’s the use of antibiotics.
6th ed. ASM pres, Washington DC, 2010:601-620.
5) Stuart RL..
Moxifloxacin. In: Grayson ML. (ed) Kucher’s the use
of antibiotics. 6th ed. ASM pres, Washington
DC, 2010: 1412-28.
6)Moller NF. Fosfomycin. In: Grayson
ML. (ed) Kucher’s the use of antibiotics.
6th ed. ASM pres, Washington DC, 2010:935-44.
7) Bartolussi R, Mailman TL. Listeriosis. In: Remington J, Klein J, Wilson
C, Nizet V, Maldonado Y. (eds) Infectious Diseases
of the Fetus and Newborn, 7th ed., Elsevier 2010:470-88.
8) Bartlett JG Fver of unknown origin.
John Hopkins Point IT: Point of care information technology. ABX Guide.
9) Korczak D, Schöffmann C.
Medizinische Wirksamkeit und Kosten-efektivat von Praventions und Kontrollmass
nehmen gegen Methicillin-resistente Staphylococcus aureus (MRSA)-Infektionen im
Krankenhaus Therapie. Deutchen Institute für Medizinische Dokumentation und
Information. Köln, 2010.
10) Nossent JC. Adult-onset Still's
disease. In: Hochberg HC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH. (eds)
Rheumatology. 5th ed. Newyork, Churchill
Livingstone, Elsevier 2011:1190-1229.
11) Tessier J, Scheld WM. Bacterial
infections of the central nervous system. In: Finch RG, Greenwood D, Norrby SR,
Whitlry RJ. (eds) Antibiotic and Chemotherapy.
9th ed. Newyork, Churchill Livingstone, Elsevier 2011:1190-1229.
12) Hawkey PM. The control of ESBL
producing bacteria. In: Gould IM, van der Meer JWM. (eds) Antibiotic policies controlling hospital-acquired
infection. Newyork, Springer 2012:91-104.
13) Burkholder TH, Linton G, Hoyt RF,
Young R. The rabbit as an experimental model. In: Suckow MA, Stevens KA, Wilson
RP (eds) The Laboratory Rabbit, Guinea Pig,
Hamster, and Other Rodents. Academic press, Elsevier, New York
2012:530-562.
14) Delong D. Bacterial diseases. In:
Suckow MA, Stevens KA, Wilson RP (eds) The
Laboratory Rabbit, Guinea Pig, Hamster, and Other Rodents. Academic
press, Elsevier, New York 2012:301-363.
15) Forster, P. (2012) To Pandemic or
Not? Reconfiguring Global Responses to Influenza, STEPS Working Paper 51,
Brighton: STEPS Centre.
16) Jaradat, Z.W. Bacterial
meningitis, molecular diagnosis and epidemiological typing: A review (2012) Meningitis: Causes, Diagnosis and Treatment, pp.
83-140.
17) Al-Anazi KA, Al Jasser AM.
Brucellosis: A Global Re-emerging Zoonosis; Clinical Aspects, Associations and
Brucellosis in Specific Conditions. Bacterial and mycotic infections in
immunocompromised hosts: clinical and microbiological aspects. Omics books,
2013.
18) Hall WA, Kim PD. Neurosurgical infectious Diseases. Thieme, 2013.
19) Livorsi D, Stenehjem E, Gaynes R. Multidrug-resistant bacteria: the
emerging crisis. In: Fong IW (ed) Challenges in
infectious diseases. Springer, New York, 2013:47-88.
20) Hicks LL. Health insurance. In: Hicks LL (ed) Economics of health and medical care. Jones &
Bartlett Publishers, 2014:267-96.
21)Fisher RG. Providencia. In: Cherry
J et al (eds) Feigin and Cherry's Textbook of
Pediatric Infectious Diseases. 7th ed. Newyork, Churchill Livingstone,
Elsevier 2014.
22) Dowling PM. Miscellaneous
Antimicrobials: Ionophores, Nitrofurans, Nitroimidazoles, Rifamycins, and
Others In: Giguere, S; Prescott, JF; Dowling, PM (eds) Antimicrobial
Therapy in Veterinary Medicine. 5th ed. 2013:315-332.
23) Amsterdam D. Antibiotics in
laboratory medicine. 6th ed, Walters Kluwer 2015.
24) Amsterdam D. Antibiotics in
laboratory medicine. 6th ed, Walters Kluwer 2015.
25) Amsterdam D. Antibiotics in
laboratory medicine. 6th ed, Walters Kluwer 2015.
26) Scheld WM, Whitley RJ, Marra CM.
Acute bacterial meningitis. Infections of the
central nervous system. 4th ed. 2014:364-419.
27) Scheld WM, Whitley RJ, Marra CM.
Acute bacterial meningitis. Infections of the
central nervous system. 4th ed. 2014:364-419.
28) Scheld WM, Whitley RJ, Marra CM.
Acute bacterial meningitis. Infections of the
central nervous system. 4th ed. 2014:364-419.
29) Anstead, G. M.,
Cadena, J., & Javeri, Treatment of Infections Due to Resistant
Staphylococcus aureus. In: Methicillin-Resistant
Staphylococcus aureus (MRSA) Protocols. 2nd Ed Humana Pres, 2014;1085:
259-309.
30) Kollmann TR, Mailman TL. Bartolussi R. Listeriosis. In: Wilson CB,
Nizet V, Maldonado Y. Remington JS, Klein JO, (eds) Infectious
Diseases of the Fetus and Newborn, 7th ed., Elsevier 2014:457-74.
31)Yu, W.-L.,
Chuang, Y.-C. Clinical characteristics and outcome of Klebsiella pneumoniae
meningitis in adult patients
(2014) Bacterial Meningitis: Clinical
Characteristics, Modes of Transmission and Treatment Options, pp. 61-86.
32)Maslow MJ, Portal-Celhay C
Rifamycins In: Bennett JE, Dolin R, Blaser MJ (eds) Mandell,
Douglas, and Bennett's Principles and Practice of Infectious Diseases
8th ed. 2015:339-349e3
33)Tunkel AR, van de Beek D, Scheld
WM. Acute meningitis. In: Bennett JE,
Dolin R, Blaser MJ (eds) Mandell, Douglas, and
Bennett's Principles and Practice of Infectious Diseases 8th ed.
2015:31097-1137e8.
34) Tunkel AR, van de Beek D, Scheld
WM. Acute meningitis. In: Bennett JE,
Dolin R, Blaser MJ (eds) Mandell, Douglas, and
Bennett's Principles and Practice of Infectious Diseases 8th ed.
2015:31097-1137e8.
35)Tunkel AR, van de Beek D, Scheld
WM. Acute meningitis. In: Bennett JE,
Dolin R, Blaser MJ (eds) Mandell, Douglas, and
Bennett's Principles and Practice of Infectious Diseases 8th ed.
2015:31097-1137e8.
36) Gul HC, Erdem H. Brucellosis
(Brucella species). In: Bennett JE,
Dolin R, Blaser MJ (eds) Mandell, Douglas, and
Bennett's Principles and Practice of Infectious Diseases 8th ed.
2015:2584-2589e3.
37) Gul HC, Erdem H. Brucellosis
(Brucella species). In: Bennett JE,
Dolin R, Blaser MJ (eds) Mandell, Douglas, and
Bennett's Principles and Practice of Infectious Diseases 8th ed.
2015:2584-2589e3.
38) Gul HC, Erdem H. Brucellosis
(Brucella species). In: Bennett JE, Dolin
R, Blaser MJ (eds) Mandell, Douglas, and Bennett's
Principles and Practice of Infectious Diseases 8th ed. 2015:2584-2589e3.
39)Edwards JE, Jr. Candida species.
In: Bennett JE, Dolin R, Blaser MJ (eds) Mandell,
Douglas, and Bennett's Principles and Practice of Infectious Diseases 8th
ed. 2015:2879-2894e3.
40) Horton JM Urinay tract agents:
nitrofurantoin, fosfomycin and methenamine. In: Bennett JE, Dolin R, Blaser MJ
(eds) Mandell, Douglas, and Bennett's Principles
and Practice of Infectious Diseases 8th ed. 2015:447-451e.
41) Kamaya A, Wong-You-Cheong J.
Diagnostic Ultrasound: Abdomen and Pelvis. Elsevier Health Sciences, 2015.
42) Kenneth Kaushansky, Marshall
Lichtman, Josef Prchal, Marcel M. Levi, Oliver Press, Linda Burns, Michael
Caligiuri Williams Hematology, 9th ed Mc Graw Hill, 2015:395.
43) Jabri, F.F. Antimicrobial
consumption and multidrug resistant organisms in intensive care units: Lessons
from Saudi Arabia. (2015) Transforming Public Health in Developing Nations, pp.
209-240.
44) Pulcini C. "Tackling
antimicrobial resistance through prescription control in human health"
Antimicrobial resistance control 2015. Overcoming global
antimicrobial resistance. 2015:62.
45) Salaaeen S, Peng M, Biswas
D.Replacement of Conventional Antimicrobials and Preservatives in Food
Production to Improve Consumer Safety and Enhance Health Benefits. Edited by:
Rai, VR; Bai, JA
Microbial food safety and preservation
techniques. 2015: 305-327.
46)Manivasagan, Panchanathan, et al.
"Marine Actinobacterial Metabolites and their Pharmaceutical
Potential." Hb25_Springer Handbook of Marine Biotechnology. Springer
Berlin Heidelberg, 2015. 1371-1386.
47)Cecchini, Michele, Julia Langer,
and Luke Slawomirski. "Antimicrobial resistance in g7 caountries and
beyond:
Economic Issues, Policies and Options for
Action and Options for Action." OECD (2015).
48)Salaheen S, Peng M, Biswas D.
Replacement of conventional antibiotics and preservatives in food production to
improve consumer safety and enhance health benefits. In: Rai VR and Bai JA
(eds). Microbial Food Safety and Preservation
Techniques 2015:305-28.
49)Nosocomial meningitis.
Goldman-Cecil Medicine, Lee Goldman, Andrew I. Schafer Elsevier Science Health
Science,2015.
50)Meningitis. Goldman-Cecil Medicine,
Lee Goldman, Andrew I. Schafer Elsevier Science Health Science,2015
51)Geldern, Gloria, and Avindra Nath.
"Central nervous system infections." Evidence-Based Neurology:
Management of Neurological Disorders: 129-142.
52)Remington and Klein's Infectious
Diseases of the Fetus and Newborn Infant. Yazar: Christopher B. Wilson,Victor Nizet,Yvonne Maldonado,Jerome O. Klein,Jack S.
Remington Elsevier Health Sciences, 2015
Science Citation Index-Expanded kapsamındaki dergilerde yapılan
atıflar/Citations in the Science Citation Index
1)Kisa O, Albay A, Bedir O, et al.Evaluation of FASTPplaqueTB-RIF (TM) for determination of
rifampicin resistance in Mycobacterium tuberculosis complex isolates. International Journal of Tuberculosis and Lung Disease
2003;7: 284-288.
2)Boylu S, Ozbas S, Bozdag AD, et al.
Effect of perioperative feeding with fibre & arginine on morphometrics of
ileum after surgical stress. Indian Journal of Medical
Research 2005;122: 120-126.
3)Demirer S, Aydintug S, Aslim B, et
al. Effects of probiotics on radiation-induced intestinal injury in rats. Nutrition 2006; 22: 179-186.
4)Tuncyurek P, Sari
M, Firat O, et al. Does pharmaconutrition with L-arginine and/or
alpha-tocopherol improve the gut barrier in bile duct ligated rats? European Surgical Research 2006;38: 4-10.
5)von Specht M, Gardella N,
Tagliaferri P, Gutkind G, Mollerach M. Methicillin-resistant Staphylococcus
aureus in community-acquired meningitis. European
Journal of Clinical Microbiology and Infectious Diseases 2006; 25:
267-269
6)Metan G, Sardan YC, Hascelik
G.Brucellosis in all patients with febrile neutropenia.Leukemia and Lymphoma
2006;47: 954-6.
7)Rahman, Md.A.,
Jun, A., Matsumoto, N., Ishikawa, T., Kamei, C. Epileptogenic activity of
methicillin-resistant Staphylococcus aureus (MRSA) antibiotics in rats. Biological and Pharmaceutical Bulletin 2006;
29:2035-2040.
8)Arca EA, Karabiber N Short
communication: Comparison of susceptibilities of Escherichia coli urinary tract
isolates against fosfomycin tromethamine and different antibiotics. Mikrobiyoloji Bülteni 2007;41: 115-119.
9)Bettinetti G, Sorrenti M, Cat enacci
L, Ferrari F, Rossi S, Salvadeo I, Carraro P Solid-state interactions and drug
release of teicoplanin in binary combinations with peracetylated α-,
β-, and γ-cyclodextrins Journal of Inclusion Phenomena and
Macrocyclic Chemistry 2007; 57: 329-332
10) Melzer M, Petersen I Mortality
following bacteraemic infection caused by extended spectrum beta-lactamase
(ESBL) producing E. coli compared to non-ESBL producing E. coli Journal of Infection 2007;55:254-259.
11)Lia L, Chena X, Daia X, Chenc H,
Zhonga D Rapid and selective liquid chromatographic/tandem mass spectrometric
method for the determination of fosfomycin in human plasma. Journal of
Chromatography B 2007; 856: 171-177.
12)Demirer S, Ulusu NN, Aslim B,
Kepenekci I, Ulusoy C, Andrieu MN, Erkek B, Aydintug S Protective effects of
Lactobacillus delbrueckii subsp bulgaricus B3 on intestinal enzyme activities
after abdominal irradiation in rats. Nutrition Research 2007;27: 300-305
13)Perez F, Endimiani A, Hujer KM,
Bonomo RA The continuing challenge of ESBLs Current Opinion in Pharmacology
2007;7: 459-469
14)Pea F, Viale P Pharmacodynamics of
antibiotics to treat multidrug-resistant Gram-positive hospital infections. Expert Review of Anti-infective Therapy 2007;5:
255-270.
15)Pea F, Viale P Pharmacodynamics of
antibiotics to treat multidrug-resistant Gram-positive hospital infections. Expert Review of Anti-infective Therapy 2007;5:
255-270.
16)Rodríguez-Baño J, Navarro MD. Impact
of ESBL on empirical therapy and antibiotic policies. Enfermedades Infecciosas
y Microbiologica Clinica 2007;25 Suppl 2:54-9.
17)Guzel A, Er U, Tatli M, Aluclu MU,
Ozekinci T, Nergiz Y, Ahishali B, Aktas G, Kavak V, Nergiz S, Ozkan U, Satici
O. An experimental Staphylococcus aureus meningitis model for investigating
induced leptomeningeal and subpial inflammation in rats: a transmission
electron microscopy study. Neuroendocrinology Letters 2007;28(5):652-8.
18)Rodríguez-Baño J, Navarro MD.
Extended-spectrum beta-lactamases in ambulatory care: a clinical perspective.
Clinical Microbiology and Infection, 2008; 14 s1: 104-110.
19)Buijs J, Dofferhoff ASM, Mouton JW,
Wagenvoort JHT, van der Meer JWM Concentration-dependency of
β-lactam-induced filament formation in Gram-negative bacteria Clinical
Microbiology and Infection 2008;14:344-9.
20) Al-Tawfiq JA Therapeutic options
for human brucellosis. Expert Review of Anti-Infective Therapy 2008;6:109-120.
21)Falagas ME, Giannopoulou KP,
Kokolakis GN, Rafailidis PI. Fosfomycin: Use Beyond Urinary Tract and
Gastrointestinal Infections. Clinical Infectious Diseases 2008;46:1069–1077
22)Lee BY. Digital Decision Making:
Computer Models and Antibiotic Prescribing in the Twenty-First Century.
Clinical Infectious Diseases 2008;46:1139–1141
23)Pullukcu H, Aydemir Ş, Taşbakan MI,
Çilli F, Tünger A, Ulusoy S, Susceptibility of Extended-Spectrum
Beta-Lactamase-Producing Escherichia coli Urine Isolates to Fosfomycin,
Ciprofloxacin, Amikacin and Trimethoprim-Sulfamethoxazole. Turkish Journal of
Medical Sciences 2008; 38: 175-180.
24)Gutierrez OL, Ocampo CL, Aguilera
JR, Luna J, Sumano LH Pharmacokinetics of disodium-fosfomycin in mongrel dogs.
Research in Veterinary Science 2008;31:321-327.
25)Huang JH, Hsu Br Treatment of
infective endocarditis caused by methicillin-resistant Staphylococcus aureus:
Teicoplanin versus vancomycin in a retrospective study Scandinavian Journal of
Infectious Diseases
2008;40:462-67.
26)Huang JH, Hsu Br Treatment of
infective endocarditis caused by methicillin-resistant Staphylococcus aureus:
Teicoplanin versus vancomycin in a retrospective study Scandinavian Journal of
Infectious Diseases
2008;40:462-67.
27)Pigrau C, Rodriguez-Pardo MD.
Infections associated with the use of indwelling urinary catheters, infections
related to intrauterine devices. Enfermedades Infecciosas y Microbiologica
Clinica 2008;26:299-310.
28)Prendergast A, Walls T, Turner P,
Cubitt D, Hartley J, Klein N, Novelli V. Comment on: Antimicrobial policies in
the neonatal units of the United Kingdom and Republic of Ireland. Journal of
Antimicrobial Chemotherapy 2008;61:429-430.
29)Tullio V, Cuffini AM, Banche G,
Mandras N, Allizond V, Roana J, Giacchino F, Bonello F, Ungheri D, Carlone NA.
Role of fosfomycin tromethamine in modulating non-specific defence mechanisms
in chronic uremic patients towards ESBL-producing Escherichia coli.
International Journal of Immunopathology and Pharmacology 2008;21:153-60.
30) Mensa J, Barberán J, Llinares P,
Picazo J, Bouza E, Alvarez-Lerma F, Borges M, Serrano R, León C, Guirao X,
Arias J, Carreras E, Sanz M, García-Rodríguez J.Guidelines for the treatment on
infections caused by methicillin-resistant Staphylococcus aureus. Revista
Espanola Quimioterapia. 2008;21:234-58.
31)Connor BA, Patron DJ. Use of an
accelerated immunization schedule for combined hepatitis A and B protection in
the corporate traveler. Journal of Occupational and Environmental Medicine
2008;50:945-950.
32)Rodríguez-Baño J, Alcalá JC, Cisneros
JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M,
Esteve M, Peña C, Llanos AC, Cantón R, Pascual A.Community infections caused by
extended-spectrum beta-lactamase-producing Escherichia coli. Archives of
Internal Medicine. 2008;168(17):1897-902.
33)Yilmaz E, Akalin H, Ozbey S, Kordan
Y, Sinirtaş M, Gürcüoglu E, Ozakin C, Heper Y, Mistik R, Helvaci S.Risk factors
in community-acquired/onset urinary tract infections due to extended-spectrum
beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.Journal
of Chemotherapy 2008;20:581-5.
34)Grayo S, Lott-Desroches MC,
Dussurget O, Respaud R, Fontanet A, Join-Lambert O, Singlas E, Le Monnier A.
Rapid eradication of Listeria monocytogenes by moxifloxacin in a murine model
of central nervous system listeriosis. Antimicrobial Agents and Chemotherapy
2008; 52:3210-315.
35) Rodríguez-Baño J, Pascual
A.Clinical significance of extended-spectrum beta-lactamases. Expert Review of
anti-infective Therapy 2008;6:671-83.
36)Akyar I. Antibiotic resistance
rates of extended spectrum beta-lactamase producing Escherichia coli and
Klebsiella spp. strains isolated from urinary tract infections in a private
hospital. Mikrobiyoloji Bulteni 2008;42:713-5.
37)Akçali A, Levent B, Akbaş E, Esen
B. Typing of Shigella sonnei strains isolated in some provinces of Turkey using
antimicrobial resistance and pulsed field gel electrophoresis methods.
Mikrobiyoloji Bulteni 2008;42:563-72.
38)Smith CL, Geier MS, Yazbeck R,
Torres DM, Butler RN, Howarth GS.Lactobacillus
fermentum BR11 and fructo-oligosaccharide partially reduce jejunal inflammation in a model of intestinal
mucositis in rats.Nutrition and Cancer 2008;60(6):757-67.
39)Gul HC, Erdem H, Gorenek L, Ozdag
MF, Kalpakci Y, Avci IY, Besirbellioglu BA, Eyigun CP. Management of
neurobrucellosis: an assessment of 11 cases. Internal Medicine 2008;47:995-1001.
40)Madaule S, Delavignea K, Charlata
I. Paradox of fever of unknown origin. Médecine Nucléaire 2008;32:161-172
41)Ozyurt M, Oncul O, Ceylan S,
Haznedaroglu T, Sahiner F, Ardic N. Cross-resistance and associated resistance
in Escherichia coli isolates from nosocomial urinary tract infections between
2004–2006 in a Turkish Hospital. Central European Journal of Medicine 2008;3:446-52.
42)Kim BN, Peleg AY, Lodise TP, Lipman
J, Li J, Nation R, Paterson DL. Management of meningitis due to
antibiotic-resistant Acinetobacter species. Lancet Infectious Diseases 2009;
9(4):245-55.
43)Uçkay I, Vernaz-Hegi N, Harbarth S,
Stern R, Legout L, Vauthey L, Ferry T, Lübbeke A, Assal M, Lew D, Hoffmeyer P,
Bernard L.Activity and impact on antibiotic use and costs of a dedicated
infectious diseases consultant on a septic orthopaedic unit..Journal
of Infection. 2009;58(3):205-12
44)Prakash V, Lewis JS 2nd, Herrera
ML, Wickes BL, Jorgensen JH. Oral and Parenteral Therapeutic Options for
Outpatient Urinary Infections Caused by CTX-M ESBL-Producing
Enterobacteriaceae. Antimicrobial Agents and Chemotherapy. 2009;53:1278-80
45) Perlova O, Gerth K, Kuhlmann S,
Zhang Y, Müller R.Novel expression hosts for complex secondary metabolite megasynthetases:Production of myxochromide in the
thermopilic isolate Corallococcus macrosporus GT-2. .Microbial Cell Factories
2009 Jan 6;8:1.
46)Xie FH, Chao YP, Xue ZQ, Yang XQ , Zhang GQ, Shi JJ, Qian SJ. Stereoselective epoxidation of cis-propenylphosphonic
acid to fosfomycin by a newly isolated bacterium Bacillus simplex strain S101.
Journal of Industrial Microbiology and Biotechnology. 2009;36:739-746.
47)Magliani W, Conti S, Cunha RLOR, Travassos
LR, Polonelli L. Antibodies as Crypts of Antiinfective and Antitumor Peptides.
Current Medicinal Chemistry 2009;16:2305-2323.
48)Schneidewind A, Ehrenstein B,
Salzberger B. Infections as causes of fever of unknown origin. Der Internist
2009;50:669-57.
49)Chiang CC, Tsai YY, Lin JM, Chen WL.Chronic endophthalmitis after cataract surgery secondary
to Ochrobactrum anthropi. Eye 2009;23:1237-38.
50) da Silva DF, Mezencio JMD, Vanetti
MCD, Cecon PR, dos Santos ML. Translocation of Klebsiella sp in mice fed an
enteral diet containing prebiotics. Brazililian Journal of Nutrition.2009;22:229-235.
51)Kurtaran B, Paydas S, Yavuz S,
Candevir A. Richter’s Transformation; the Cause of Fever of Unknown Origin in a
Case with Chronic Lymphocytic Leukemia. International Journal of Hematology and
Oncology 2009; 19:180-183.
52)Chavanet P. Presumptive bacterial meningitis in adults:
Initial antimicrobial therapy. Médecine et Maladies Infectieuses 2009;39:499-512.
53)Chavanet P. Presumptive bacterial meningitis in adults:
Initial antimicrobial therapy. Médecine et Maladies Infectieuses 2009;39:499-512.
54)Stahl JP. Treatment of community
acquired bacterial meningitis, after microbiological identification Médecine et
Maladies Infectieuses 2009;39:513-20.
55) Ansart S. Antibiotic management of
presumptive bacterial meningitis in adults (rational, methods, course, and
follow-up). Médecine et Maladies Infectieuses 2009;39:629-646.
56) Deghmane AE, Alonso JM, Taha MK.Emerging drugs for acute bacterial meningitis.Expert
Opinion on Emerging Drugs. 2009;14:381-393.
57) Vidal E, Ly K,Fauchais AL, Monteil
J. Fever of unknown origin. Medecine Nucleaire 2009;33:522-532.
58) Miranda J, Tunkel AR Strategies
and New Developments in the Management of Bacterial Meningitis. Infectious Disease
Clinics of North America, 2009;23:925-943.
59) Miranda J, Tunkel AR Strategies
and New Developments in the Management of Bacterial Meningitis. Infectious
Disease Clinics of North America, 2009;23:925-943.
60) Miranda J, Tunkel AR Strategies
and New Developments in the Management of Bacterial Meningitis. Infectious
Disease Clinics of North America, 2009;23:925-943.
61) Miranda J, Tunkel AR Strategies
and New Developments in the Management of Bacterial Meningitis. Infectious
Disease Clinics of North America, 2009;23:925-943.
62) Raffi F. Community-acquired
bacterial meningitis: Main lessons from the French National Consensus
Conference, November 2008. Antibiotiques
2009;11:199-205.
63) Hosbul T et al. In vitro activity
of fosfomycin tromethanol in the treatment of Escherichia coli related
uncomplicated urinary tract infections. Mikrobiyoloji Bulteni 2009;43:645-649.
64) Allerberger F, Gareis R, Jindrák
V, Struelens MJ. Antibiotic stewardship implementation in the EU: the way
forward. Expert Review of
Anti Infective Therapy. 2009 Dec;7(10):1175-83.
65) Falagas ME, Roussos N, Gkegkes ID,
Rafailidis PI, Karageorgopoulos DE. Fosfomycin for the treatment of infections
caused by Gram-positive cocci with advanced antimicrobial drug resistance: a
review of microbiological, animal and clinical studies. Expert Opinion on
Investigational Drugs. 2009;18(7):921-44.
66) Nudelman Y, Tunkel AR. Bacterial
meningitis: epidemiology, pathogenesis and management update. Drugs
2009;69(18):2577-96.
67) Fanego RBC, Dorta-Contreras AJ,
Padilla-Docal B, O'Farril-Sanchez M, Lopez-Hernandez I. Clinical behavior of
Streptococcus pneumoniae meningoencephalitis. Arquivos de Neuro-psiquiatria
2009;67:1023-1028.
68) Karanika M, Vasilopoulou VA,
Katsioulis AT, Papastergiou P, Theodoridou MN, Hadjichristodoulou CS.
Diagnostic clinical and laboratory findings in response to predetermining
bacterial pathogen: data from the Meningitis Registry.
PLoS One. 2009 Jul 29;4(7):e6426.
69) Pei-Feng L, Chih-Wei L; Chao-Hsuan
C; Ming-Fa H; Chun-Ming H. Use of Nanoparticles as Therapy for
Methicillin-Resistant Staphylococcus aureus Infections. Current Drug Metabolism
2009; 10:875-884.
70) Philippe J, Nollet F, Bakkus M, et
al.Guidelines for an integrated diagnostic approach of
chronic lymphoproliferative diseases in the routine laboratory of haematology
in Belgium. Acta Clinica Belgica 2009: 64: 494-504.
71) Gennai S, François P, Bal G,
Epaulard O, Stahl JP, Vittoz JP, Pavese P. Evaluation of a remote infectious
disease consultation. Médecine et Maladies Infectieuses 2009;39:798-805.
72) Giulano C, Haase KK, Hall R. Use
of vancomycinpharmacokinetic-pharmacodynamic properties in the treatment of
MRSA infections. . Expert Review of Anti Infective Therapy 2010
Jan;8(1):95-106.
73) Falagas ME, Katoris AC, Kapaskelis
AM, Karageorgopoulos DE. Fosfomycin for the treatment of multidrug-resistant,
including extended-spectrum β-lactamase producing, Enterobacteriaceae
infections: a systematic review. Lancet Infectious Diseases 2010; 10: 43-50.
74) Sellier E, Pavese P, Gennai S,
Stahl JP, Labarère J, François P. Factors and outcomes associated with
physicians' adherence to recommendations of infectious disease consultations
for inpatients. Journal of Antimicrobial Chemotherapy 2010;65:156-162.
75) Roger PM, Brofferio P, Labatec C,
Barrière JR, Minguet JM, Foulon P, Zumbo C and l’ensemble du corps médical du
centre hospitalier de la Dracénie. Prospective evaluation of antibiotic
combinations in a general hospital. Médecine et Maladies Infectieuses 2010;40:165-171.
76) Forrest GN, Tamura K. Rifampin
combination therapy for nonmycobacterial infections. Clinical Microbiology
Reviews 2010 Jan;23(1):14-34.
77) Popovic M, Steinort D, Pillai S,
Joukhadar C.Fosfomycin: an old, new friend? European Journal of Clinical
Microbiology and Infectious Diseases. 2010;29:127-142..
78) Demiroğlu YZ, Turunc T, Aşiskan H,
Çolakoğlu Ş, Erdoğan AF, Arslan H. Community Acquired
Meningitis/meningoencephalitis: Retrospective Evaluation Of Five Years. Turkiye
Klinikleri Journal of Medical Sciences 2010;30:218-26.
79) Efstathiou SP, Pefanisa AV,
Tsiakoua AG, Skevaa II, Tsioulosa DI, Achimastosa AD,Mountokalakisa
TD. Fever of unknown origin: Discrimination between infectious and
non-infectious causes. European Journal of Internal Medicine 2010;21:137-143.
80) Al Kandari M, Jamala W, Udo
EE, El Sayed A, Al Shammri S, Rotimi VO.
A Case of Community-Onset Meningitis Caused by Hospital Methicillin-Resistant
Staphylococcus aureus Successfully Treated with Linezolid and Rifampicin.
Medical Principles and Practice 2010;19:235-239.
81) Chena X, Xua J, Muc X, Hud Y, Huc
G, Duanc H, Zhangc T, Linc H, Zhanga W. Effects of rhynchophylline and
isorhynchophylline on nitric oxide and endothelin-1 secretion from RIMECs
induced by Listeriolysin O in vitro. Veterinary Microbiology 2010; 143:262-269.
82) Cavalcanti AB, Goncalves AR,
Almeida CS , Bugano DDG, Silva E. Teicoplanin versus vancomycin for proven or
suspected infection. Cochrane Database of Systematic Reviews. 2010; 6:
CD007022
83) Uluğ M, Uluğ NC. Adult-onset
Still's Disease in the Etiology of Fever of Unknown Origin and Review of the
Literature. Turkish Journal of Physical Medicine and Rehabilitation 2010;56:97-99.
84) Moawad MA, Bassil H, Elsherif M,
Ibrahim A, Elnaggar M, Edathodu J, Alharthi A, Albugami M, Sabry A, Shoukri M,
Bakhsh I, Laudon U. Fever of unknown origin: 98 cases from Saudi Arabia. Annals
of Saudi Medicine 2010;30:289-94
85) Brouwer MC, Tunkel AR, van de Beek
D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial
meningitis. Clinical Microbiology Reviews 2010;23(3):467-92.
86) Metelmann C, Schulz K,
Geldschlager-Canda R, Plotz S, Handrick W. Listeriosis in adults - case reports
and review of the literature. Wiener Klinische Wochenschrift 2010;122:354-359.
87) Veena Kumari HB, Nagaraja D,
Nagarathna S, Kulkarni GB, Praveen CS, Nadig S, Arakere G. A variant epidemic
methicillin resistant Staphylococcus aureus-15 cavernous sinus thrombosis and
meningitis: A rare occurrence with unusual presentation. Indian Journal of
Medical Microbiology 2010;28:255-7
88) Erdem H, Kilic S, Coskun O, Ersoy
Y, Cagatay A, Onguru P, Alp S.Community acquired acute bacterial meningitis in
the elderly in Turkey. Clinical Microbiology and Infection 2010;16:1223-29.
89) Soemirien Kasanmoentalib E,
Brouwer MC, van der Ende A, van de Beek D. Hydrocephalus in adults with
community-acquired bacterial meningitis. Neurology. 2010;75(10):918-23.
90) Avkan-Oguz V, Yapar N, Ozakbas S,
Demir-Onder K, Aktas E, Alp-Cavus S, Ozkal S, Men S, Kargi A. A case of fever
of unknown origin: co-existence of
91) Kikuchi-Fujimoto disease and acute
disseminated encephalomyelitis (ADEM). Internal
Medicine 2010;49(16):1823-6.
92) Ulug M, Celen MK, Geyik MF, Tekin
R, Ayaz C. Nasopharyngeal carcinoma in the etiology of fever of unknown origin.
Nobel Medicus 2010;6:93-96.
93) Soysal D, Yusufoğlu MC, Karakuş V,
Türkkan E, Küçükşahin O, Tatar E, Özatlı T, Uyanık Ö, Şener G, Uzun S. An
Overall View on Nosocomial Infections in an Intensive Care Unit. Turkiye Klinikleri
Journal of Medical Sciences 2010;30(4):1143-53.
94) Kurt H, Karabay O, Birengel S,
Memikoglu O, Yılmaz Bozkurt G, Yalçın A. Effects of Legal Antibiotic
Restrictions on Consumption of Broad-Spectrum Beta-Lactam Antibiotics,
Glycopeptides and Amphotericin B. Chemotherapy 2010;56:359-63.
95) Bayrak E, Dönderici Ö, Serter R,
Efe FK. A Case with Fever of Unknown Origin Diagnosed as Wegener
Granulomatosis. Turkish Journal of Rheumatology 2010;25:159-61.
96) Carmoi T, Grateau G, Billhot M,
Dumas G, Biale L, Perrot G, Algayres JP. [Prolonged
fever: Specific issues in the young adult population. La Revue Medicine Interne
2010;31: 838-45.
97) Behar PRP, Wagner MB, Petersen LC,
Vilas Boas MR. Is antibiotic prescribing on Saturdays higher than any other day
of the week? Journal of Hospital Infection 2010;76:84-85.
98) Buzgan T, Karahocagil MK, Irmak H,
Binici İ, Karsen H, Akdeniz H. Retrospective evaluation of 204 meningitis
cases. Turkiye Klinikleri Journal of Medical Sciences 2010;30(5):1675-82.
99) Spyropoulos BG, Misiakos EP,
Fotiadis C, Stoidis CN. Antioxidant Properties of Probiotics and Their
Protective Effects in the Pathogenesis of Radiation-Induced Enteritis and
Colitis. Digestive Diseases and Sciences. 2011;56:285-94.
100) Goff DA. Antimicrobial
stewardship: bridging the gap between quality care and cost. Current opinion in
Infectious Diseases 2011 Feb;24 Suppl 1:S11-20.
101) Gennai S, François P, Sellier E,
Vittoz JP, Hincky-Vitrat V, Pavese P. Prospective study of telephone calls to a
hotline for infectious disease consultation: analysis of 7,863 solicited
consultations over a 1-year period. European Journal of Clinical Microbiology
and Infectious Diseases 2011;30:509-14.
102) Lo YY, Lam CL, Mercer SW, Fong
DY. Does vocational training in family medicine have an impact on antibiotic
prescribing pattern? Family Practice 2011;28:56-62.
103) Yucel N, Citak S, Bayhün S.
Antimicrobial Resistance Profile of Staphylococcus aureus Isolated from
Clinical Samples and Foods of Animal Origin. Foodborne Pathogens and Disease
2011; 8:427-31.
104) Lungu B et al. Listeria
monocytogenes: Antibiotic Resistance in Food Production. Foodborne Pathogens
and Disease. 2011;8(5):569-78.
105) Asli AA, Moghadami M, Zamiri N,
Tolide-Ei HR, Heydari ST, Alavian SM, Lankarani KB. Vaccination against
hepatitis B among prisoners in Iran: Accelerated vs. classic vaccination.
Health Policy. 2011;100:297-304.
106) Çalık Ş, Gökengin D Human
brucellosis in Turkey: a review of the literature between 1990 and 2009.
Turkish Journal of Medical Sciences 2011;41:549-55.
107) Kawanami GH, Fortaleza CM.
Factors predictive of inappropriateness in requests for parenteral
antimicrobials for therapeutic purposes: A study in a small teaching hospital
in Brazil. Scandinavian Journal of Infectious Diseases. 2011; 43(6-7):528-35.
108) Pavese P, Sellier E, Laborde L,
Gennai S, Stahl JP, François P. Requesting physicians' experiences regarding
infectious disease consultations. BMC Infectious Diseases. 2011 Mar 14;11:62.
109) Zi-jun Z, Ying-li Z, Yong-hua HU
Effect and cost of perioperative use of antibiotics in coronary artery bypass
grafting: a randomized controlled study. Chinese Medical Journal, 2011, 124:
699-703.
110) Coskun O, Erdem H, Avci A.
Management of community-acquired acute bacterial cystitis in Turkey. Turkish
Journal of Medical Sciences 2011;41:149-57.
111) Coskun O, Erdem H, Avci A.
Management of community-acquired acute bacterial cystitis in Turkey. Turkish
Journal of Medical Sciences 2011;41:149-57.
112) Citak EC, Arman D. Brucella melitensis:
a rare cause of febrile neutropenia. Pediatric Hematology Oncology 2011
Feb;28(1):83-5.
113) Majid HA, Emery PW, Whelan K.
Faecal microbiota and short-chain fatty acids in patients receiving enteral
nutrition with standard or fructo-oligosaccharides and fibre-enriched formulas.
Journal of Human Nutrition and Dietetetics. 2011; 24(3):260-8
114) García-Hernández AM,
García-Vázquez E, Hernández-Torres A, Ruiz J, Yagüe G, Herrero JA, Gómez J.
[Bacteraemia due to Escherichia coli producing extended-spectrum betalactamases
(ESBL): clinical relevance and today's insights. Revista Espanola de
Quimioterapia 2011 Jun;24(2):57-66.
115) Roshan M, Ikram A, Mirza IA,
Malik N, Abbasi SA, Alizai SA. Susceptibility pattern of extended spectrum
ß-lactamase producing isolates in various clinical specimens. J Coll Physicians
Surg Pak. 2011 Jul;21(7):342-6.
116) Doyle JS, Buising KL, Thursky KA,
Worth LJ, Richards MJ. Epidemiology of infections acquired in intensive care
units. Semin Respir Crit Care Med. 2011 Apr;32(2):115-38.
117) Cutter J. Commentary: the
importance of education and vaccination in reducing the risk of hepatitis infection among
nursing students. Int Nurs Rev. 2011 Jun;58(2):186-7.
118) Mook-Kanamori BB, Geldhoff M, van
der Poll T, van de Beek D. Pathogenesis and pathophysiology of pneumococcal
meningitis. Clinical Microbiology Reviews 2011;24(3):557-91.
119) Andersson DI, Hughes D.
Persistence of antibiotic resistance in bacterial populations. FEMS Microbiol
Rev. 2011 Sep;35(5):901-11.
120) Gumral R, Yıldızoglu U, Saracli
MA, Kaptan K, Tosun F, Yildiran ST. A Case of Rhinoorbital Mucormycosis in a
Leukemic Patient with a Literature Review from Turkey. Mycopathologia.
2011;172:397-405.
121) Gumral R, Yıldızoglu U, Saracli
MA, Kaptan K, Tosun F, Yildiran ST. A Case of Rhinoorbital Mucormycosis in a
Leukemic Patient with a Literature Review from Turkey. Mycopathologia.
2011;172:397-405.
122) Butcu M, Akcay SS, Inan AS,
Aksaray S, Engin DO, Calisici G. In vitro susceptibility of enterococci strains
isolated from urine samples to fosfomycin and other antibiotics. Journal of
Infection and Chemotherapy. 2011;17:575-8.
123) Ciftdoğan DY, Bayram N, Vardar F.
Brucellosis as a Cause of Fever of Unknown Origin in Children Admitted to a
Tertiary Hospital in the Aegean Region of Turkey. Vector Borne Zoonotic
Diseases 2011;11:1037-40.
124) Drekonja DM, Johnson JR.
Tigecycline treatment for urinary tract infections: case report and literature
review. Journal of Chemotherapy 2011 Jun;23(3):168-70.
125) Pogue JM, Marchaim D, Kaye D,
Kaye KS. Revisiting "older" antimicrobials in the era of multidrug
resistance. Pharmacotherapy. 2011 Sep;31(9):912-21.
126) Michalopoulos AS, Livaditis IG,
Gougoutas V. The revival of fosfomycin. International Journal of Infectious
Diseases. 2011;15: E732-39.
127) Coghe F, Orrù G, Pautasso M,
Ferraguti P, Sanna P, Fanos V. The role of the laboratory in choosing
antibiotics. J Matern Fetal Neonatal Med. 2011 Oct;24 Suppl 2:18-20.
128) Ciçek M, Uçmak F, Ozekinci T.
[Two diarrhea cases caused by cyclospora cayetanensis]. Mikrobiyoloji Bülteni
2011 Jul;45(3):553-7.
129) Wu D, Chang H, Wang Y, Xin M.
Isolation, structure determination and antibacterial activities of succinamide
conjugate diacid from Acinetobacter sp. BJ-L. Microbiological Research 2011 Mar
20;166(3):155-60.
130) Brouwer MC, Spanjaard L, Prins
JM, van der Ley P, van de Beek D, van der Ende A. Association of chronic
meningococcemia with infection by meningococci with underacylated
lipopolysaccharide. Journal of Infection. 2011 Jun;62(6):479-83.
131) Agrawal S, Nadel S. Acute
bacterial meningitis in infants and children: epidemiology and management.
Paediatric Drugs. 2011 Dec 1;13(6):385-400.
132) Aguilar-Díaz FD, Jiménez-Corona
ME, Ponce-de-León-Rosales S. Influenza Vaccine and Healthcare Workers. Arch Med
Res. 2011;42:652-57.2
133)Özkurt Z, Altoparlak U, Yilmaz S,
Erol S, Ozden K, Akcay MN. Reducing
hospital infection rates in the burn unit by adherence to infection control
measures: a six-year experience. Turkish Journal of Medical Sciences 2012;42:10-24.
134)Özkurt Z, Altoparlak U, Yilmaz S,
Erol S, Ozden K, Akcay MN. Reducing
hospital infection rates in the burn unit by adherence to infection control
measures: a six-year experience. Turkish Journal of Medical Sciences 2012;42:10-24
135) Clifford RJ et al Complete genome
sequence of Providencia stuartii clinical isolate MRSN 2154. Journal of
Bacteriology. 2012 Jul;194(14):3736-7.
136) Ersoy Y, Yetkin F, Bayraktar MR,
Ersoy Y, Yologlu S. A New Diagnostic Scoring for Discrimination of Tuberculous and
Bacterial Meningitis on the Basis of
Clinical and Laboratory Findings. Medical Principles and Practice. 2012;21:259-63.
137) Chen PD, Yu SL, Chen S, Weng XH.
Retrospective study of 61 patients with adult-onset Still's disease admitted
with fever of unknown origin in China. Clinical Rheumatology. 2012;31:175-81.
138) Riphagen-Dalhuisen J, Gefenaite
G, Hak E. Predictors of seasonal influenza vaccination among healthcare workers
in hospitals: a descriptive meta-analysis. Occupational and Environmental
Medicine. 2012;69:230-5.
139) Pintado V et al.
Methicillin-Resistant Staphylococcus aureus Meningitis in Adults: A Multicenter
Study of 86 Cases. Medicine (Baltimore). 2012-01-05
140) Passoni MH, Salgado HRN
Development and validation of a new and rapid HPLC for determination of
lyophilized teicoplanin Analytic Methods 2012;4:1560-64.
141) Olga GO et al. Structure of a
polysaccharide from Providencia rustigianii O11 containing a novel amide of
2-acetamido-2-deoxygalacturonic acid with l-glutamyl-l-alanine, Carbohydrate
Research 2012;349:95-102.
142) File, TM. Duration and cessation
of antimicrobial treatment. Journal of Hospital Medicine, 2012;7 (supp 1):
s22-s33.
143) Rosenberg, D.J. Infections, bacterial resistance, and
antimicrobial stewardship: The emerging role of hospitalists. Journal of
Hospital Medicine, 2012;7: S34–S43.
144) Çiçek C et al. Molecular typing
and sequencing of adenovirus isolated from a conjunctivitis outbreak in a
neonatal intensive care unit by PCR. Turkish Journal of Medical Sciences 2012;
42 (Sup.2): 1365-1369.
145) Dommergues MA, Hentgen V.
Decreased paediatric antibiotic consumption in France between 2000 and 2010.
Scand J Infect Dis. 2012;44:495-501.
146) de la Torre ,
Tena D, Arias M and Romanillos O. Recurrent prosthetic joint infection
due to Salmonella enteritidis: case report and literature review. European
Journal of Orthopaedic Surgery & Traumatology 2012; 22 (supp 1): 89-97.
147) Okay OS, Li K, Yediler A, Karacik
B. Determination of selected antibiotics in the Istanbul strait sediments by
solid-phase extraction and high performance liquid chromatography. J Environ
Sci Health A Tox Hazard Subst Environ Eng. 2012 Aug;47(10):1372-80.
148) Ovchinnikova OG, Kocharova NA,
Bialczak-Kokot M, Shashkov AS, Rozalski A, Knirel Y. A. Structure of the
O-Polysaccharide of Providencia alcalifaciens O22 Containing D-Glyceramide
2-Phosphate. Eur. J. Org. Chem..2012;18:3500-3506.
149) Cicek M, Palanci Y, Ceylan A,
Ozekinci T, Kaya M. Evaluation of demographic, clinic and treatment features of
patients and a cross-sectional survey of cyclosporiasis in patients with
diarrhea in Southeastern Turkey. African Journal of Microbiology Research 2012;6:2949-2955.
150) Bozca B; Ozgenc O; Avci M; Yucel
ES. Investigation of Sixty Extrapulmonary Tuberculosis Cases Türkiye Klinikleri
Tıp bilimleri Dergisi
2012;32:66-73.
151) Galac MR, Lazzaro BP. Comparative
genomics of bacteria in the genus Providencia isolated from wild Drosophila
melanogaster. BMC Genomics. 2012;13(1):612.
152) Guner SN, Gokturk B, Bayrakci US
et al.The distrubition of community-acquired gram
negative microorganisms isolated from the urine samples of children, and the
evaluation of increase in antibiotic resistance between the years 2003-2010. Turkish
Archives of Pediatrics 2012;47:107-13.
153) Shin SH, Kim KS. Treatment of
bacterial meningitis: an update. Expert Opin Pharmacother. 2012
Oct;13(15):2189-206.
154) Ishaq M, NAziri L, Riaz A, Alam
SM, Shaikh MI. ‘The eyes see what the mind knows.’ Adult-onset Still's disease,
a case series and review in a south Asian population. International Journal of
Rheumatic Diseases. 2012;15: E96-100.
155) Mete B et al. The role of
invasive and non-invasive procedures in diagnosing Fever of unknown origin. Int
J Med Sci. 2012;9(8):682-9.
156) Erdem H, Akova M. Leading
infectious diseases problems in Turkey. Clin Microbiol Infect. 2012
Nov;18(11):1056-67.
157) Erdem H, Akova M. Leading
infectious diseases problems in Turkey. Clin Microbiol Infect. 2012
Nov;18(11):1056-67.
158) Erdem H, Akova M. Leading
infectious diseases problems in Turkey. Clin Microbiol Infect. 2012
Nov;18(11):1056-67.
159) Erdem H, Akova M. Leading
infectious diseases problems in Turkey. Clin Microbiol Infect. 2012
Nov;18(11):1056-67.
160) Göçmen S, Öcal S, Atabey C ve
ark. The Descriptive of Long Hospitalization Patients (More than 6 Months) in
Neurosurgery Intensive Care Unit. Türk Nöroşirürji Dergisi 2012;22:92-99.
161) Ardic N. Antimicrobial Resistance
Status of E. coli and K. pneumoniae Strains Isolated from Inpatients: Five-Year
Data. Turk J Phys Med Rehab 2012;58:189-93.
162) Picazo JJ, Alonso LM, Arístegui J
et al [Consensus document on vaccination against influenza in health care
workers]. Rev Esp Quimioter. 2012 Sep;25(3):226-39.
163) Neuner EA, Sekeres J, Hall GS,
van Duin D. Experience with fosfomycin for treatment of urinary tract
infections due to multidrug-resistant organisms. Antimicrob Agents Chemother.
2012 Nov;56(11):5744-8.
164) Keshtkar-Jahromi M et al. Medical
versus medical and surgical treatment for Brucella endocarditis. Ann Thorac
Surg. 2012 Dec;94(6):2141-6.
165) Ovchinnikova OG, Liu B, Guo D,
Kocharova NA, Bialczak-Kokot M, Shashkov AS, Feng L, Rozalski A, Wang L, Knirel
YA. Structural, serological and genetic characterization of the O-antigen of
Providencia alcalifaciens O40. FEMS Immunol Med Microbiol. 2012;66:382-92.
166) Karakaş A, Turhan V. Problem of
antibiotic resistance in patients with acute bacterial cystitis and treatment
options. Turkish Journal of Medical Sciences 2012; 42 (Sup.2): 1542-1543
167) Balkhed AO, Tärnberg M, Monstein
HJ, Hällgren A, Hanberger H, Nilsson LE. High frequency of co-resistance in
CTX-M-producing Escherichia coli to non-beta-lactam antibiotics, with the
exceptions of amikacin, nitrofurantoin, colistin, tigecycline, and fosfomycin,
in a county of Sweden. Scand J Infect Dis. 2013 Apr;45(4):271-8.
168) Gao X, Lu Y, Xing Y, Ma Y, Lu J,
Bao W, Wang Y, Xi T. A novel anticancer and antifungus phenazine derivative
from a marine actinomycete BM-17. Microbiological Research. 2012 Dec
20;167(10):616-22.
169) Abedi G et al. Assessment of
quality of life in hepatitis B patients compared with healthy people. Life
Science Journal 2012;9(4):5339-43.
170) Wilson DT, May DB. Potential Role
of Fosfomycin in the Treatment of Community-Acquired Lower Urinary Tract
Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia
coli. American Journal of Therapeutics. 2013;20:685-90.
171) Wilson DT, May DB. Potential Role
of Fosfomycin in the Treatment of Community-Acquired Lower Urinary Tract
Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia
coli. American Journal of Therapeutics 2013;20:685-90.
172) Doi A, Shimada T, Harada S, Iwata
K, Kamiya T. The efficacy of cefmetazole against pyelonephritis caused by
extended-spectrum beta-lactamase-producing Enterobacteriaceae. Int J Infect
Dis. 2013 Mar;17(3):e159-63.
173) Tuells J, Caballero P, Nolasco A.
[Beliefs, attitudes and influence of the media in Spanish health care workers
during the A (H1N1) 2009 flu pandemic.]. Enferm Infecc Microbiol Clin. 2013
Jun-Jul;31(6):369-74.
174) Turhan V, Salmanoğlu M, Karagoz
E, Onem Y. Is antimicrobial treatment alone sufficient for Brucella
endocarditis, and if it is, which antibiotics should we use? Int J Antimicrob
Agents. 2013;41:201-02.
175) Lesprit P, Landelle C,
Brun-Buisson C. Unsolicited post-prescription antibiotic review in surgical and
medical wards: factors associated with counselling and physicians' compliance.
Eur J Clin Microbiol Infect Dis. 2013;32:227-35.
176) Socan M, Erculj V, Lajovic J.
Knowledge and attitudes on pandemic and seasonal influenza vaccination among
Slovenian physicians and dentists. Eur J Public Health. 2013 Feb;23(1):92-7.
177) Erdem H et al. Diagnosis of
chronic brucellar meningitis and meningoencephalitis: the results of the
Istanbul-2 study. Clin Microbiol Infect. 2013 Feb;19(2):E80-6.
178) Ulu-Kilic A, Sayar MS, Tütüncü E,
Sezen F, Sencan I. Complicated brucellar spondylodiscitis: experience from an
endemic area. Rheumatol Int. 2013;33:2909-12.
179) Hüseynov B et al. Effect of
melatonin on contractile activity in intraurethral instilled E.Coli- induced
acute prostatitis rat model. Turkish Journal of Medical Sciences 2013;43:905-12.
180) Avci YA et al. Demonstration of
mutations conferring resistance to lamivudine in liver tissue of chronic
hepatitis B patients under lamivudine therapy. Turkish Journal of Medical
Sciences 2013;43:199-202.
181) Ma Y, Li F, Chen L. Widespread
Hypermetabolic Lesions Due to Multicentric Form of Castleman Disease as the
Cause of Fever of Unknown Origin Revealed by FDG PET/CT. Clin Nucl Med. 2013;38:835-37.
182) Coulibaly D, Nzussouo NT, Kadjo
HA, et al. Pandemic Influenza A(H1N1) in Cote d'Ivoire: health-care providers'
knowledge of influenza and attitudes towards vaccination. J Infect Dev Ctries.
2013 Jul 15;7(7):499-506.
183) Maiti TK, Singh VK, Pandey P.
Providencia rettgeri: An Unusual Cause of Central Nervous System Infections. Am
J Med Sci. 2013 Aug;346(2):158-9.
184) Hofinger D, Davis LE. Bacterial
meningitis in older adults. Curr Treat Options Neurol. 2013 Aug;15(4):477-91.
185) Chen YW, Liu CC, Perng DS.
Perceptions about preventing hepatocellular carcinoma among patients with
chronic hepatitis in Taiwan. World J Gastroenterol. 2013 Jun 14;19(22):3459-65.
186) Qiao LD, Zheng
B, Chen S, Yang Y, Zhang K, Guo HF, Yang B, Niu YJ, Wang Y, Shi BK, Yang WM,
Zhao XK, Gao XF, Chen M. Evaluation of three-dose fosfomycin tromethamine in
the treatment of patients with urinary tract infections: an uncontrolled,
open-label, multicentre study. BMJ
Open. 2013 Dec 4;3(12):e004157.
187) Qiao LD, Zheng
B, Chen S, Yang Y, Zhang K, Guo HF, Yang B, Niu YJ, Wang Y, Shi BK, Yang WM,
Zhao XK, Gao XF, Chen M. Evaluation of three-dose fosfomycin tromethamine in
the treatment of patients with urinary tract infections: an uncontrolled,
open-label, multicentre study. BMJ
Open. 2013 Dec 4;3(12):e004157.
188) Pinto CS, Nunes B, Branco MJ,
Falcão JM. Trends in influenza vaccination coverage in Portugal from 1998 to
2010: effect of major pandemic threats. BMC Public Health. 2013 Dec
5;13(1):1130.
189)
Xu J, Duan X, Wu H, Zhou Q. Surveillance and Correlation of
Antimicrobial Usage and Resistance of Pseudomonas aeruginosa: A Hospital
Population-Based Study. PLoS One. 2013 Nov 8;8(11):e78604.
190) Domínguez A et al. CIBERESP
Working Group for the Survey on Influenza Vaccination in Primary Health Care Workers.
Knowledge of and attitudes to influenza vaccination in healthy primary
healthcare workers in Spain, 2011-2012. PLoS One. 2013 Nov 18;8(11):e81200.
191) Aykan SB, Ciftci IH. [Antibiotic
Resistance Patterns of Escherichia coli Strains Isolated from Urine Cultures in
Turkey: A Meta-Analysis]. Mikrobiyol Bul. 2013 Oct;47(4):603-18.
192) Aykan SB, Ciftci IH. [Antibiotic
Resistance Patterns of Escherichia coli Strains Isolated from Urine Cultures in
Turkey: A Meta-Analysis]. Mikrobiyol Bul. 2013 Oct;47(4):603-18.
193) Erdem H et al. Withdrawal of
Staphylococcus aureus from intensive care units in Turkey. Am J Infect Control.
2013 Nov;41(11):1053-8.
194) Demir NA et al. Level of
knowledge and compliance to hand hygiene among health care workers. Nobel
Medicus 2013;9:104-9.
195) Keating GM. Fosfomycin
trometamol: a review of its use as a single-dose oral treatment for patients
with acute lower urinary tract infections and pregnant women with asymptomatic
bacteriuria. Drugs. 2013 Nov;73(17):1951-66.
196) Keating GM. Fosfomycin
trometamol: a review of its use as a single-dose oral treatment for patients
with acute lower urinary tract infections and pregnant women with asymptomatic
bacteriuria. Drugs. 2013 Nov;73(17):1951-66.
197) Keating GM. Fosfomycin
trometamol: a review of its use as a single-dose oral treatment for patients
with acute lower urinary tract infections and pregnant women with asymptomatic
bacteriuria. Drugs. 2013 Nov;73(17):1951-66.
198) Bonfiglioli R, Vignoli M,
Guglielmi D, Depolo M, Violante FS. Getting vaccinated or not getting
vaccinated? Different reasons for getting vaccinated against seasonal or
pandemic influenza. BMC Public Health. 2013 Dec 21;13:1221.
199) Meryem I et al. Streptococcus
dysgalactiae Subspecies Equisimilis; An Agent Rarely Encountered in the
Etiology of Septic Arthritis. Jundishapur Journal of Microbiology 2013; 6: UNSP
e9175.
200) Spyropoulos BG et al. The effect
of synbiotics on acute radiation-induced diarrhea and its association with
mucosal inflammatory and adaptive responses in rats. Dig Dis Sci. 2013
Sep;58(9):2487-98.
201) Mensa J et al; Sociedad Española
de Quimioterapia (SEQ); Sociedad Española de Medicina Interna (SEMI);
GTIPO-Sociedad Española de Anestesiología y Reanimación. [Guidelines for
antimicrobial treatment of the infection by Staphylococcus aureus]. Rev Esp
Quimioter. 2013 Jan;26 Suppl 1:1-84.
202) Mshana SE, Hain T, Domann E,
Lyamuya EF, Chakraborty T, Imirzalioglu C. Predominance of Klebsiella
pneumoniae ST14 carrying CTX-M-15 causing neonatal sepsis in Tanzania. BMC
Infect Dis. 2013 Oct 7;13:466.
203) Zhao L, Li W, Zhu S, Tsai S, Li
J, Tracey KJ, Wang P, Fan S, Sama AE, Wang H. Green tea catechins quench the
fluorescence of bacteria-conjugated Alexa fluor dyes. Inflamm Allergy Drug
Targets. 2013 Oct;12(5):308-14.
204) Nau R, Djukic M, Spreer A,
Eiffert H. Bacterial meningitis: new therapeutic approaches. Expert Rev Anti
Infect Ther. 2013 Oct;11(10):1079-95.
205) Nau R, Djukic M, Spreer A,
Eiffert H. Bacterial meningitis: new therapeutic approaches. Expert Rev Anti
Infect Ther. 2013 Oct;11(10):1079-95.
206) Nau R, Djukic M, Spreer A,
Eiffert H. Bacterial meningitis: new therapeutic approaches. Expert Rev Anti
Infect Ther. 2013 Oct;11(10):1079-95.
207) Lee SS, Wong NS, Lee S. Declining
influenza vaccination coverage among nurses, Hong Kong, 2006-2012. Emerg Infect
Dis. 2013 Oct;19(10):1660-3.
208) Mahmood K et al. Fever of unknown
origin at a teritiary care teaching hospital in Pakistan. The Southeast Asian
journal of tropical medicine and public health 2013;44: 503-511.
209) Martínez-Baz I, Díaz-González J,
Guevara M, Toledo D, Zabala A, Domínguez A, Castilla J. [Attitudes, perceptions
and factors associated with influenza vaccination among primary healthcare
professionals in Navarre, 2011-2012]. An Sist Sanit Navar. 2013 Sep
6;36(2):263-73.
210) Vehreschild JJ et al. Evaluation
of an infectious disease consultation programme in a German tertiary care
hospital. Infection. 2013 Dec;41(6):1121-8.
211) Harris G, Kuo Lee R, Lam CK,
Kanzaki G, Patel GB, Xu HH, Chen W. A mouse model of Acinetobacter baumannii-associated
pneumonia using a clinically isolated hypervirulent strain. Antimicrob Agents
Chemother. 2013 Aug;57(8):3601-13.
212) Avkan-Oguz V, Yapar N, Alp-Cavus
S, Demir Onder K, Aktas E, Gulay Z, Cakır N. Clinical and microbiological
efficacy of tigecycline for complicated skin-soft-tissue and intra-abdominal
infections in a Turkish university hospital. Int J Clin Pract. 2013
Jun;67(6):505-11.
213) Saran B, Erdem B, Tekeli FA,
Sahin F, Aysev AD. [Characterization of Shigella strains isolated in ankara, Turkey
by antimicrobial resistance models, plasmid profile
analysis and pulsed-field gel electrophoresis]. Mikrobiyol Bul. 2013
Jan;47(1):35-48.
214) Hatipoglu N, Hatipoglu H.
Combination antifungal therapy for invasive fungal infections in children and
adults. Expert Rev Anti Infect Ther. 2013 May;11(5):523-35.
215) Bi LQ, Zhou J, Huang M, Zhou SM.
Efficacy of linezolid on gram-positive bacterial infection in elderly patients
and the risk factors associated with thrombocytopenia. Pak J Med Sci. 2013
May;29(3):837-42.
216) Xu J, Sun Z, Li Y, Zhou Q.
Surveillance and Correlation of Antibiotic Consumption and Resistance of
Acinetobacter baumannii complex in a Tertiary Care Hospital in Northeast China,
2003–2011. International Journal of Environmental Research and Public Health.
2013; 10(4):1462-1473.
217) Chen, YH et al. Emerging
resistance problems and future perspectives in pharmacotherapy for complicated
urinary tract infections. Expert opinion on pharmacotherapy 2013;14: 587-596.
218) Jackson J, Chen C, Buising K.
Aminoglycosides: how should we use them in the 21st century? Curr Opin Infect
Dis. 2013 Dec;26(6):516-25.
219) Pigrau C. [Nocosomial urinary
tract infections]. Enferm Infecc Microbiol Clin. 2013 Nov;31(9):614-24.
220) Demir T, Buyukguclu T. Evaluation
of the in vitro activity of fosfomycin tromethamine against Gram-negative
bacterial strains recovered from community-and hospital-acquired urinary tract
infections in Turkey. Int J Infect Dis. 2013 Nov;17(11):e966-70.
221) Kesav P, Vishnu VY, Khurana D. Is
neurobrucellosis the Pandora's Box of modern medicine? Clin Infect Dis. 2013
Oct;57(7):1056-7.
222) Pogue JM, Marchaim D,
Abreu-Lanfranco O, Sunkara B, Mynatt RP, Zhao JJ, Bheemreddy S, Hayakawa K,
Martin ET, Dhar S, Kaye KS, Lephart PR. Fosfomycin activity versus
carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-10. J
Antibiot (Tokyo). 2013 Oct;66(10):625-7.
223) Pogue JM, Marchaim D,
Abreu-Lanfranco O, Sunkara B, Mynatt RP, Zhao JJ, Bheemreddy S, Hayakawa K,
Martin ET, Dhar S, Kaye KS, Lephart PR. Fosfomycin activity versus
carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-10. J
Antibiot (Tokyo). 2013 Oct;66(10):625-7.
224) Kazak E, Aslan E, Akalın H,
Saraydaroğlu O, Hakyemez B, Erişen L, Yazıcı B, Gürcüoğlu E, Yılmaz E, Ener B,
Helvacı S. A mucormycosis case treated with a combination of caspofungin and
amphotericin B. J Mycol Med. 2013 Sep;23(3):179-84.
225) Castilla J, Martínez-Baz I, Godoy
P et al; CIBERESP Working Group for the Survey on Influenza Vaccination in
Primary Healthcare Professionals. Trends in influenza vaccine coverage among
primary healthcare workers in Spain, 2008-2011. Prev Med. 2013Sep;57(3):206-11.
226) Kaya A, Ergul N, Kaya SY, Kilic
F, Yilmaz MH, Besirli K, Ozaras R. The management and the diagnosis of fever of
unknown origin. Expert Rev Anti Infect Ther. 2013 Aug;11(8):805-15.
227) Guven T, Ugurlu K, Ergonul O,
Celikbas AK, Gok SE, Comoglu S, Baykam N, Dokuzoguz B. Neurobrucellosis: clinical
and diagnostic features. Clin Infect Dis. 2013 May;56(10):1407-12.
228) Ashbaugh AR, Herbert CF, Saimon
E, Azoulay N, Olivera-Figueroa L, Brunet A. The decision to vaccinate or not
during the H1N1 pandemic: selecting the lesser of two evils? PLoS One.
2013;8(3):e58852.
229) Barichello T, Generoso JS,
Milioli G, Elias SG, Teixeira AL. Pathophysiology of bacterial infection of the
central nervous system and its putative role in the pathogenesis of behavioral
changes. Rev Bras Psiquiatr. 2013 Mar;35(1):81-7.
230) Modabbernia A, Ashrafi M,
Malekzadeh R, Poustchi H. A review of psychosocial issues in patients with
chronic hepatitis B. Arch Iran Med. 2013Feb;16(2):114-22.
231) Domínguez A, Godoy P, Castilla J,
Soldevila N, Toledo D, Astray J, Mayoral JM, Tamames S, García-Gutiérrez S,
González-Candelas F, Martín V, Díaz J, Torner N; CIBERESP Working Group for the
Survey on Influenza Vaccination in Primary Health Care Workers. Knowledge of
and attitudes to influenza vaccination in healthy primary healthcare workers in
Spain, 2011-2012. PLoS One. 2013 Nov18;8(11):e81200.
232) Feyzioglu B et al. Rapid
Dissemination of Multidrug Resistant Providencia Stuartii- A University
Hospital Based Study. Biomedical
Research 2014; 25 (1): 104-109.
233) Göçmez C, Celik F, Tekin R,
Kamaşak K, Turan Y, Palancı Y, Bozkurt F, Bozkurt M. Evaluation of risk factors
affecting hospital-acquired infections in the eurosurgery intensive care unit.
Int J Neurosci. 2014 Jul;124(7):503-8.
234) Jansåker F, Frimodt-Møller N,
Sjögren I, Dahl Knudsen J. Clinical and bacteriological effects of
pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in
urinary tract infections. J Antimicrob Chemother. 2014 Mar;69(3):769-72.
235) Jansåker F, Frimodt-Møller N,
Sjögren I, Dahl Knudsen J. Clinical and bacteriological effects of
pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in
urinary tract infections. J Antimicrob Chemother. 2014 Mar;69(3):769-72.
236)Wagenlehner FM, Thomas PM, Naber
KG. Fosfomycin Trometamol (3,000 mg) in Perioperative Antibiotic Prophylaxis of
Healthcare-Associated Infections after Endourological Interventions: A
Narrative Review. Urol Int. 2014;92(2):125-30.
237)Güven T et al. Increasing
resistance of nosocomial Acinetobacter baumannii:are
we going to be defeated? Turk J Med Sci 2014;44: 73-78.
238)Merres J et al. Role of the
Cathelicidin-Related Antimicrobial Peptide in Inflammation and Mortality in a
Mouse Model of Bacterial Meningitis. J Innate Immun. 2014;6(2):205-18.
239)Cenderello G, Pontali E, Torresin
A, Milano G, Ansaldi F, Feasi M, Usiglio D, Mori M, Icardi G, Cassola G. An
unexpected Streptococcus pneumoniaestrain. J Chemother. 2014 Jun;26(3):173-5.
240)Qu TT et al. Fosfomycin resistance
among vancomycin-resistant enterococci owing to transfer of a plasmid
harbouring the fosB gene. International journal of antimicrobial agents. 2014
Apr;43(4):361-5.
241) Tan YC, Gill AK, Kim KS.
Treatment strategies for central nervous system infections: an update. Expert
Opin Pharmacother. 2014 Oct 18:1-17.
242) Tan YC, Gill AK, Kim KS.
Treatment strategies for central nervous system infections: an update. Expert
Opin Pharmacother. 2014 Oct 18:1-17.
243) Kılıç B. Diagnostic methods for
Osteomyelitis. Advances in Environmental Biology 8.13 (2014): 573-581.
244) Dokuzeylul B et al. Early
detection of septic arthritis caused by Streptococcus dysgalactiae subspecies
equisimilis in a dog–a case report. Acta Veterinaria Brno, 2014; 83: 261-264.
245) Concia E, Azzini AM. Aetiology
and antibiotic resistance issues regarding urological procedures. J Chemother.
2014 Oct;26 Suppl 1:S14-23.
246) Atabey C et al. Nosocomial
Infections Caused by Jugular Central Venous Catheterization in Brain Surgery
Intensive Care Unit. Journal of Neurological Sciences (Turkish), 2014; 31:
557-567.
247) Akalın Ş et al. Seroprevalence of
human cystic echinococcosis and risk factors in animal breeders in rural
communities in Denizli, Turkey. The Journal of Infection in Developing
Countries, 2014; 8: 1188-1194.
248) Guerin F et al. Overexpression of
the Novel MATE Fluoroquinolone Efflux Pump FepA in Listeria monocytogenes Is
Driven by Inactivation of Its Local Repressor FepR. PloS one, 2014,;9.9: e106340.
249) Rajendran S et al. Determination
of MIC Distribution of Arbekacin, Cefminox, Fosfomycin, Biapenem and Other
Antibiotics against Gram-Negative Clinical Isolates in South India: A
Prospective Study. PloS one, 2014; 9.7: e103253.
250) Pulcini C, Botelho-Nevers E, Dyar
OJ, Harbarth S. The impact of infectious disease specialists on antibiotic
prescribing in hospitals. Clin Microbiol Infect. 2014 Oct;20(10):963-72.
251) Pulcini C, Botelho-Nevers E, Dyar
OJ, Harbarth S. The impact of infectious disease specialists on antibiotic
prescribing in hospitals. Clin Microbiol Infect. 2014 Oct;20(10):963-72.
252)Wen JT et al Multidrug-resistant
genes of aminoglycoside-modifying enzymes and 16S rRNA methylases in
Acinetobacter baumannii strains. Genetics and molecular research: GMR, 2014,;13: 3842.
253) Wu Q et al. Adsorption Behavior
of Nitrofurantoin onto Multiwalled Carbon Nanotubes and Magnetite
(Fe3O4)-loaded Multiwalled Carbon Nanotubes from Aqueous Solution. Journal of
Dispersion Science and Technology, 2014;36:821-30.
254) Park SH et al. The efficacy of non-carbapenem
antibiotics for the treatment of community-onset acute pyelonephritis due to
extended-spectrum β-lactamase-producing Escherichia coli. Journal of
Antimicrobial Chemotherapy, 2014 Oct;69(10):2848-56.
255) Poulikos P et al. Combination
antibiotic treatment versus monotherapy for multidrug-resistant, extensively
drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic
review. European Journal of Clinical Microbiology & Infectious Diseases,
2014 Oct;33(10):1675-85.
256) Senbayrak-Akcay S et al.. Gram-negative bacilli causing infections in an intensive
care unit of a tertiary care hospital in Istanbul, Turkey. The Journal of
Infection in Developing Countries, 2014 May 14;8(5):597-604.
257) Senbayrak-Akcay S et al.. Gram-negative bacilli causing infections in an intensive
care unit of a tertiary care hospital in Istanbul, Turkey. The Journal of
Infection in Developing Countries, 2014 May 14;8(5):597-604.
258) Hajia M et al. Real-time assay as
a tool for detecting lytA gene in streptococcus pneumoniae lsolates. Cell J.
2014; 16 (2): 141-146.
259) Erdem H et al. The features of
infectious diseases departments and anti-infective practices in France and
Turkey: a cross-sectional study. Eur J Clin Microbiol Infect Dis. 2014
Sep;33(9):1591-9.
260) Albano L et al. Knowledge,
attitudes and behaviour of hospital health-care workers regarding influenza
A/H1N1: a cross sectional survey. BMC infectious diseases, 2014; 14: 208.
261) Albayrak N et al. [Investigation
of the presence of Mycobacterium tuberculosis in the lymph node aspirates of
the suspected tularemia lymphadenitis cases]. Mikrobiyol Bul. 2014
Jan;48(1):129-34.
262) Juhász, Z.,
Benkő, R., Matuz, M., Viola, R., Soós, Gy., Hajdú, E. [Treatment practice
of acute cystitis on the basis of
national prescription data]. Orv. Hetil.,
2014;155:,590–596.
263) Souza-Borgez FRF et al.
Occupational exposures to body fluids and behaviors regarding their prevention
and post-exposure among medical and nursing students at a Brazilian public
university. Revista do Instituto de Medicina Tropical de São Paulo, 2014;56:
157-163.
263) Zhang Q et al. Clinical Value of
Dual-phase 18F-FDG SPECT with Serum Procalcitonin for Identification of
Etiology in Tumor Patients with Fever of Unknown Origin. Asian Pacific Journal
of Cancer Prevention, 2014, 15.2: 683-686.
265) Ozturk-Engin D et al. Liver
involvement in patients with
brucellosis: results of the Marmara study. Eur J Clin Microbiol
Infect Dis. 2014 Jul;33(7):1253-62.
266) Ozturk-Engin D et al. Liver
involvement in patients with
brucellosis: results of the Marmara study. Eur J Clin Microbiol
Infect Dis. 2014 Jul;33(7):1253-62.
267) Wali IE et al. Combined activity
of garlic and nitrofurantoin against Escherichia coli and Enterococcus species
recovered from urinary tract infections. African Journal of Microbiology
Research, 2014,;8: 644-651.
268) Hsu Aj et al. Pranita D. The
treatment of multi-drug resistant Gram-negative infections in children.
Clinical Infectious Diseases, (2014) 58 (10): 1439-1448.
269) Ingram PR et al. What do infectious
diseases physicians do? A 2-week snapshot of inpatient consultative activities
across Australia, New Zealand and Singapore. Clin Microbiol Infect. 2014
Oct;20(10):O737-44.
270) Martins HS, Bomfim MR, França RO,
Farias LM, Carvalho MA, Serufo JC, Santos SG. Resistance markers and genetic
diversity in Acinetobacter baumannii strains recovered from nosocomial
bloodstream infections. Int J Environ Res Public Health. 2014 Jan
28;11(2):1465-78.
271) Macvane SH et al. Impact of
extended‐spectrum
β‐lactamase–producing
organisms on clinical and economic outcomes in patients with urinary tract
infection. Journal of Hospital Medicine, 2014, 9.4:
232-238.
272) Macvane SH et al. Impact of
extended‐spectrum
β‐lactamase–producing
organisms on clinical and economic outcomes in patients with urinary tract
infection. Journal of Hospital Medicine, 2014, 9.4:
232-238.
273) Yuan S. Right-sided infective
endocarditis: recent epidemiologic changes. International journal of clinical
and experimental medicine, 2014, 7.1: 199.
274) Reffert JL, Smith WJ. Fosfomycin
for the treatment of resistant gram-negative bacterial infections. Insights from
the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2014
Aug;34(8):845-57.
275) Reffert JL, Smith WJ. Fosfomycin
for the treatment of resistant gram-negative bacterial infections. Insights from
the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2014
Aug;34(8):845-57.
276) Zhong JH. Postoperative therapy
options for hepatocellular carcinoma. Scandinavian journal of gastroenterology,
2014 Jun;49(6):649-61.
277) Zhong JH et al. Adjuvant and
chemopreventive therapies for resectable hepatocellular carcinoma: a literature
review. Tumor Biology, 2014 Oct;35(10):9459-68.
278) Loulergue P et al Vaccinations
among medical and nursing students: Coverage and opportunities. Vaccine, 2014
Aug 27;32(38):4855-9.
279) Pathoumthong K et al. Vaccination
status, knowledge and awareness towards hepatitis B among students of health
professions in Vientiane, Lao PDR. Vaccine, 2014, 32.39: 4993-4999.
280) Yogarajah M et al. Consultant
supervision of trainees seeing inpatient ward referrals–a cause for concern?. Clinical Medicine, 2014, 14.3:
268-273.
Vasilevska M, Ku J, Fisman DN. Factors
associated with healthcare worker acceptance of vaccination: a systematic
review and meta-analysis. Infect Control Hosp Epidemiol. 2014
Jun;35(6):699-708.
281) Rameauu C et al. Informal
consultation at a teaching hospital infectious diseases department. Medecine et
maladies infectieuses, 2014, 44.3: 107-111.
282) Erdem H et al. Surveillance,
control and management of infections in intensive care units in Southern
Europe, Turkey and Iran - A prospective multicenter point prevalence study. J
Infect. 2014 Feb;68(2):131-40.
283) Wang, X et al. Pathogenic
Providencia alcalifaciens Strain that Causes Fatal Hemorrhagic Pneumonia in
Piglets. Current Microbiology 2014 Mar;68(3):278-84.
284) Khan IA et al. Antimicrobial
Susceptibility Pattern of Bacteria Isolated from Patients with Urinary Tract
Infection. Journal of the College of Physicians and Surgeons Pakistan, 2014,
24.11: 840-844.
285)Cassir N et al. A new strategy to
fight antimicrobial resistance: the revival of old antibiotics. Frontiers in
Microbiology 2014; 5: 551.
286)Cassir N et al. A new strategy to
fight antimicrobial resistance: the revival of old antibiotics. Frontiers in
Microbiology 2014; 5: 551.
287)Cassir N et al. A new strategy to
fight antimicrobial resistance: the revival of old antibiotics. Frontiers in
Microbiology 2014; 5: 551.
288) Bakir M, Altinel S: Review of
invasive meningococcal disease during the last 40 years in Turkey. Expert
Review of Vaccines 2015, 14(8):1089-1097.
289) Bizo PT, Dumitras D, Popa A:
Evaluation of restricted antibiotic use in a hospital in Romania. International
Journal of Clinical Pharmacy 2015, 37(3):452-456.
290) Boyle DP, Zembower TR:
Epidemiology and Management of Emerging Drug-Resistant Gram-Negative Bacteria
Extended-Spectrum beta-Lactamases and Beyond. Urologic Clinics of North America
2015, 42(4):493-+.
291) Cheng VCC, Wong SCY, Ho P-L, Yuen
K-Y: Strategic measures for the control of surging antimicrobial resistance in
Hong Kong and mainland of China. Emerging Microbes & Infections 2015, 4.
292) Cho YH, Jung SI, Chung HS, Yu HS,
Hwang EC, Kim S-O, Kang TW, Kwon DD, Park K: Antimicrobial susceptibilities of
extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella
pneumoniae in health care-associated urinary tract infection: focus on
susceptibility to fosfomycin. International Urology and Nephrology 2015,
47(7):1059-1066.
293) Chow SF, Sheu DC, Liu CP:
Biochemical and haematological parameters and the impact of hypoalbuminaemia on
mortality in carbapenem-resistant Acinetobacter baumannii complex bacteraemia.
Research Journal of Biotechnology 2015, 10(8):11-18.
294) Cikman A, Gulhan B, Aydin M,
Ceylan MR, Parlak M, Karakecili F, Karagoz A: In vitro Activity of Colistin in
Combination with Tigecycline against Carbapenem-Resistant Acinetobacter
baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia.
International Journal of Medical Sciences 2015, 12(9):695-700.
295) Clancy E, Higgins O, Forrest MS,
Boo TW, Cormican M, Barry T, Piepenburg O, Smith TJ: Development of a rapid
recombinase polymerase amplification assay for the detection of Streptococcus
pneumoniae in whole blood. Bmc Infectious Diseases 2015, 15.
296) Cornejo-Davila V,
Palmeros-Rodriguez MA, Uberetagoyena-Tello de Meneses I, Mayorga-Gomez E,
Garza-Sainz G, Osornio-Sanchez V, Trujillo-Ortiz L, Sedano-Basilio JE,
Cantellano-Orozco M, Martinez-Arroyo C et al: Management of complicated urinary
tract infections in a referral center in Mexico. International Urology and
Nephrology 2015, 47(2):229-233.
297) de La Blanchardiere A, Dargere S,
Guerin F, Daurel C, Saint-Lorant G, Verdon R, Cattoir V: Non-carbapenem therapy
of urinary tract infections caused by extended-spectrum
beta-lactamase-producing Enterobacteriaceae. Medecine Et Maladies Infectieuses
2015, 45(5):169-172.
298) Du ZQ, Wang JY: A novel lumazine
synthase molecule from Brucella significantly promotes the immune-stimulation
effects of antigenic protein. Genetics and Molecular Research 2015,
14(4):13084-13095.
299) Elyasi S, Khalili H,
Dashti-Khavidaki S, Emadi-Koochak H: Conventional-versus high-dose vancomycin
regimen in patients with acute bacterial meningitis: a randomized clinical
trial. Expert Opinion on Pharmacotherapy 2015, 16(3):297-304.
300) Eppes CS, Clark SL:
Extended-spectrum beta-lactamase infections during pregnancy: a growing threat.
American Journal of Obstetrics and Gynecology 2015, 213(5):650-652.
301) Genthe NA, Thoden JB, Benning MM,
Holden HM: Molecular structure of an N-formyltransferase from Providencia
alcalifaciens O30. Protein Science 2015, 24(6):976-986.
302) Godoy P, Castilla J, Maria
Mayoral J, Martin V, Astray J, Torner N, Toledo D, Soldevila N,
Gonzalez-Candelas F, Garcia S et al: Influenza vaccination of primary
healthcare physicians may be associated with vaccination in their patients: a
vaccination coverage study. Bmc Family Practice 2015, 16.
303) Guldimann C, Baertschi M, Frey J,
Zurbriggen A, Seuberlich T, Oevermann A: Increased spread
and replication efficiency of Listeria monocytogenes in organotypic brain-slices
is related to multilocus variable number of tandem repeat analysis (MLVA)
complex. Bmc Microbiology 2015, 15.
304) Han SB, Lee SC, Lee SY, Jeong DC,
Kang JH: Aminoglycoside therapy for childhood urinary tract infection due to
extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella
pneumoniae. Bmc Infectious Diseases 2015, 15.
305) Harris PNA: Clinical Management
of Infections Caused by Enterobacteriaceae that Express Extended-Spectrum
beta-Lactamase and AmpC Enzymes. Seminars in Respiratory and Critical Care
Medicine 2015, 36(1):56-73.
306) Ildarabadi E, Moonaghi HK,
Heydari A, Taghipour A, Abdollahimohammad A: Vaccination learning experiences
of nursing students: a grounded theory study. Journal of Educational Evaluation
for Health Professions 2015, 12.
307) Karaman U, Daldal N, Ozer A,
Enginyurt O, Erturk O: Epidemiology of Cyclospora Species in Humans in Malatya
Province in Turkey. Jundishapur Journal of Microbiology 2015, 8(7).
308) Kim Y, Park KG, Lee K, Park Y-J:
Direct Identification of Urinary Tract Pathogens From Urine Samples Using the
Vitek MS System Based on Matrix-Assisted Laser Desorption Ionization-Time of
Flight Mass Spectrometry. Annals of Laboratory Medicine 2015, 35(4):416-422.
309) Kumari VHB, Babu AR, Srinivas D,
Siddaiah N, Somanna S: Methicillin-Resistant Staphylococcus aureus central
nervous system infections - Analysis and outcome. British Journal of
Neurosurgery 2015, 29(3):413-418.
310) Kumari VHB, Babu AR, Srinivas D,
Siddaiah N, Somanna S: Methicillin-Resistant Staphylococcus aureus central
nervous system infections - Analysis and outcome. British Journal of
Neurosurgery 2015, 29(3):413-418.
311) Kumari VHB, Babu AR, Srinivas D,
Siddaiah N, Somanna S: Methicillin-Resistant Staphylococcus aureus central nervous
system infections - Analysis and outcome. British Journal of Neurosurgery 2015,
29(3):413-418.
312) Kursun E, Turunc T, Demiroglu YZ,
Aliskan HE, Arslan AH: Evaluation of 28 cases of mucormycosis. Mycoses 2015,
58(2):82-87.
313) Lagare A, Mainassara HB, Issaka
B, Sidiki A, Tempia S: Viral and bacterial etiology of severe acute respiratory
illness among children < 5 years of age without influenza in Niger. Bmc
Infectious Diseases 2015, 15.
314) Leena B, Binita S, Reeta G: A
case of acute postoperative keratitis after deep anterior lamellar keratoplasty
by multidrug resistant Klebsiella. Indian Journal of Ophthalmology 2015,
63(4):344-U382.
315) Li G, Ren J, Wu Q, Hu D, Wang G,
Wu X, Liu S, Wu Y, Gu G, Li J: Bacteriology of Spontaneous Intra-Abdominal Abscess
in Patients with Crohn Disease in China: Risk of Extended-Spectrum
Beta-Lactamase-Producing Bacteria. Surgical Infections 2015, 16(4):461-465.
316) Liechti FD, Grandgirard D, Leib
SL: Bacterial meningitis: insights into pathogenesis and evaluation of new
treatment options: a perspective from experimental studies. Future Microbiology
2015, 10(7):1195-1213.
317) Liu M, Peng W, Qin R, Yan Z, Cen
Y, Zheng X, Pan X, Jiang W, Li B, Li X et al: The direct anti-MRSA effect of
emodin via damaging cell membrane. Applied Microbiology and Biotechnology 2015,
99(18):7699-7709.
318) Mandal PK, Chheda PR: Synthesis
of a pentasaccharide repeating unit of the O-specific polysaccharide from the
lipopolysaccharide of Providencia alcalifaciens O28. Tetrahedron Letters 2015,
56(7):900-902.
319) Mese B, Bozoglan O, Elveren S,
Eroglu E, Gul M, Celik A, Ciralik H, Yildirimdemir HI, Yasim A: Efficacy of
Linezolid, Teicoplanin, and Vancomycin in Prevention of an Experimental
Polytetrafluoroethylene Graft Infection Model caused by Methicillin-Resistant
Staphylococcus aureus. Medical Science Monitor 2015, 21:909-914.
320) Yildiz F, Bayram E, Kelle B,
Erken E: Brucella Endocarditis Presenting With Findings Resembling Vasculitis.
Archives of Rheumatology 2015, 30(1):79-82.
321)Kadavath S et al. Adult-onset
Still's disease-pathogenesis, clinical manifestations, and new treatment
options. Annals of medicine, 2015, 47.1: 6-14.
322) Oncel EK, Buyukcam A, Cengiz AB,
Kara A, Ceyhan M, Dogan BG: The Evaluation of Knowledge, Opinions, and
Attitudes of Hospital Staff Except Physicians and Nurses Regarding Seasonal
Influenza Vaccine. Journal of Pediatric Infection 2015, 9(2):68-75.
323) Parra-Ruiz J, Ramos V, Duenas C,
Coronado-Alvarez NM, Cabo-Magadan R, Portillo-Tunon V, Vinuesa D, Munoz-Medina
L, Hernandez-Quero J: Rational application of adenosine deaminase activity in
cerebrospinal fluid for the diagnosis of tuberculous meningitis. Infection
2015, 43(5).
324) Piret J, Boivin G: Innate immune
response during herpes simplex virus encephalitis and development of
immunomodulatory strategies. Reviews in Medical Virology 2015, 25(5):300-319.
325) Powers WJ: Primary Angiitis of
the Central Nervous System: Diagnostic Criteria. Neurologic Clinics 2015,
33(2):515-+.
326) Sahbudak Z: Evaluation of
Knowledge, Opinions, and Attitudes of Hospital Staff Except Physicians and
Nurses Regarding Seasonal Influenza Vaccine. Journal of Pediatric Infection
2015, 9(3):138-139.
327)
Salvarci A, Koroglu M, Gurpinar T: Evaluation of antimicrobial
activities of minocycline and rifampin-impregnated silicone surfaces in an in
vitro urinary system model. Journal of the Pakistan Medical Association 2015,
65(2):115-119.
328) Senbayrak S, Ozkutuk N, Erdem H,
Johansen IS, Civljak R, Inal AS, Kayabas U, Kursun E, Elaldi N, Savic B et al:
Antituberculosis drug resistance patterns in adults with tuberculous
meningitis: results of haydarpasa-iv study. Annals of Clinical Microbiology and
Antimicrobials 2015, 14.
329) Shakti L, Veeraraghavan B: Advantage
and limitations of nitrofurantoin in multi-drug resistant Indian scenario.
Indian Journal of Medical Microbiology 2015, 33(4):477-481.
330) Soares DM, Lima CdA, Costa FMd,
Carneiro JA: Nursing: reality of immunization against Hepatitis B in a hospital
of the north of Minas Gerais Enfermagem: realidade da imuniza磯
contra Hepatite B de um hospital do norte de Minas Gerais. Escola Anna Nery
2015, 19(4):692-701.
331) Tan YC, Gill AK, Kim KS:
Treatment strategies for central nervous system infections: an update. Expert
Opinion on Pharmacotherapy 2015, 16(2):187-203.
332) Tan YC, Gill AK, Kim KS:
Treatment strategies for central nervous system infections: an update. Expert
Opinion on Pharmacotherapy 2015, 16(2):187-203.
333) Teke TA, Koyuncu H, Oz FN, Metin
O, Bayhan GI, Aydin ZGG, Kaman A, Tanir G: Neurobrucellosis in children: Case
series from Turkey. Pediatrics International 2015, 57(4):578-581.
334) Teker B, Ogutlu A, Gozdas HT,
Ruayercan S, Hacialioglu G, Karabay O: Factors Affecting Hand Hygiene Adherence
at a Private Hospital in Turkey. Eurasian Journal of Medicine 2015,
47(3):208-212.
335) Thabit AK, Crandon JL, Nicolau
DP: Antimicrobial resistance: impact on clinical and economic outcomes and the
need for new antimicrobials. Expert Opinion on Pharmacotherapy 2015,
16(2):159-177.
336) Thabit AK, Crandon JL, Nicolau
DP: Antimicrobial resistance: impact on clinical and economic outcomes and the
need for new antimicrobials. Expert Opinion on Pharmacotherapy 2015,
16(2):159-177.
337) Theuretzbacher U, Van Bambeke F,
Canton R, Giske CG, Mouton JW, Nation RL, Paul M, Turnidge JD, Kahlmeter G:
Reviving old antibiotics. Journal of Antimicrobial Chemotherapy 2015,
70(8):2177-2181.
338) Toeroek ME: Tuberculous
meningitis: advances in diagnosis and treatment. British Medical Bulletin 2015,
113(1):117-131.
339) Trevino SE, Babcock HM, Henderson
JP, Lane MA, Beekmann SE, Polgreen PM, Marschall J: Perceptions and behaviours
of infectious diseases physicians when managing urinary tract infections due to
MDR organisms. Journal of Antimicrobial Chemotherapy 2015, 70(12):3397-3400.
340) Un S, Yilmaz Y, Yildirim M,
Akdeniz F, Turk H, Koca O: Investigation of prevalance and risk factors for
hospital-acquired urinary tract infections in patients with severe burn injury.
Ulusal Travma Ve Acil Cerrahi Dergisi-Turkish Journal of Trauma & Emergency
Surgery 2015, 21(1):57-62.
341) VanScoy BD, McCauley J,
Ellis-Grosse EJ, Okusanya OO, Bhavnani SM, Forrest A, Ambrose PG: Exploration
of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy
Using an In Vitro Infection Model. Antimicrobial Agents and Chemotherapy 2015,
59(12):7170-7177.
342) Velickovic-Radovanovic R,
Stefanovic N, Damnjanovic I, Kocic B, Antic S, Dinic M, Petrovic J, Mitic R,
Catic-Djordjevic A: Monitoring of antibiotic consumption and development of
resistance by enterobacteria in a tertiary care hospital. Journal of Clinical
Pharmacy and Therapeutics 2015, 40(4):426-430.
343) Virgilio E, Balducci G,
Mercantini P, Cavallini M: Invasive Infection of Post-Surgical
Esophagocutaneous Fistula Due to Providencia stuartii. Surgical Infections
2015, 16(6):843-844.
344) Wu Q, Xiong Z-H: Adsorption
Behavior of Nitrofurantoin onto Multi-Walled Carbon Nanotubes and Magnetite
(Fe3O4)-loaded Multi-Walled Carbon Nanotubes from Aqueous Solution. Journal of
Dispersion Science and Technology 2015, 36(6):821-830.
345) Xie J, Wang Y, Zheng X, Yang Q,
Wang T, Zou Y, Xing J, Dong Y: Modeling and forecasting Acinetobacter baumannii
resistance to set appropriate use of cefoperazone-sulbactam: Results from trend analysis of antimicrobial consumption and development
of resistance in a tertiary care hospital. American Journal of Infection
Control 2015, 43(8):861-864.
346) Nau R, Djukic M, Spreer A, Ribes
S, Eiffert H: Bacterial meningitis: an update of new treatment options. Expert
Review of Anti-Infective Therapy 2015, 13(11):1401-1423.
347) Nau R, Djukic M, Spreer A, Ribes
S, Eiffert H: Bacterial meningitis: an update of new treatment options. Expert
Review of Anti-Infective Therapy 2015, 13(11):1401-1423.
348) Nau R, Djukic M, Spreer A, Ribes
S, Eiffert H: Bacterial meningitis: an update of new treatment options. Expert
Review of Anti-Infective Therapy 2015, 13(11):1401-1423.
349) Nau R, Djukic M, Spreer A, Ribes
S, Eiffert H: Bacterial meningitis: an update of new treatment options. Expert
Review of Anti-Infective Therapy 2015, 13(11):1401-1423.
SCI-e dışı uluslar arası dergilerdeki
atıflar/Citations in other international journals
1) Clarke, E.T.,
Heyderman, R.S. Current concepts in the treatment of bacterial meningitis
beyond the neonatal period. Expert Review of Anti-Infective Therapy 2006;4: 663-674.
2) Sodqi M, Marih L, Belabbes H,
Chakib A, Marhoum El Filali K, El M’daghri N, Himmich H Streptococcus
pneumoniae meningitis in adults: review of 137 cases.Journal
Maghrebin d'anesthesie-reanimation et de medecine d'urgence 2006;13:67 -71
3) Li Yong-hong, Bai
Yu-lan, Chu Yun-zhuo Study on the
antibacterial activity of combined antibacterial agents against MRSA in vitro
Chinese Pharmacological Bulletin 2007; 2:418-419
4) Iubelan LG, Upsa AC, Diaconescu ID,
Dumitrecu F, Inescu SD, Niculescu I.Considerations on vaccination against
hepatitis B in adults. Craiova Medicala 2007;9:116-120.
5) Valentini P, Parisi G, Monaco M,
Crea F, Spanu T, Ranno O, Tronci M, Pantosti A. An uncommon presentation for a
severe invasive infection due to methicillin-resistant Staphylococcus aureus
clone USA300 in Italy: a case report.Annals of
Clinical Microbiology and Antimicrobials 2008;7:11.
6) Bean DC, Krahe D, Wareham DW.
Antimicrobial Resistance in Community and Nosocomial Escherichia coli Urinary
Tract Isolates, London 2005 - 2006. Annals of Clinical Microbiology and
Antimicrobials 2008;7:13.
7) Male KR, Mathews A, Mower J. An
unusual presentation of an unusual disease: infective endocarditis: a case
report and review of the literature. Cases Journal. 2008;1(1):292.
8) Pazderková J, Krejcí J,
Dlouhý P. Listeriosis a review of current knowledge. Klinicka
Mikrobiologie a Infekcni Lekarstvi 2008;14(4):140-4.
9)Al-Qahtani FS.Fever
of Unknown Origin: 25 years single center experience in Riyadh, Saudi Arabia.
Middle East Journal of Family Medicine 2009;7:25-27.
10) Jeon B, Lee SS, Jang WS, Lee SJ,
Kim JS, Lee JE, Kim N, Park S. Sodium Selenite Ameliorates Radiation-induced
Enteritis - Evaluating Topographic and Histologic Changes. Laboratory Animal
Research 2009;25:159-165.
11) Rikimaru T. Respiratory tract
infections: Focusing on drug-resistant pathogen. Respiration and Circulation
2009;57 (7): 741-746.
12) Artola BS, Herrejon EP.
Infecciones por listeria. Medicine - Programa de Formación Médica Continuada
Acreditado 2010;10: 3368-3372.
13) Hameed N, Tunkel AR. Treatment of
Drug-resistant Pneumococcal Meningitis. Current Infectious Disease Reports
2010;12:274-81.
14) Hardesty JS, Juang P. Recurrent
Ochrobactrum anthropi, Treatment, and Clinical Relevance. Infectious Diseases in Clinical Practice
2010;18:299-303.
15) Swaminathan S, Alangaden GJ.
Treatment of resistant enterococcal urinary tract infection. Current Infectious
Disease Reports 2010;12:455-64.
16) Boni R, Rabitti PG.Adult-onset
Still's disease, the most internistic of the rheumatic diseases: Current
concepts and a report of six cases. Italian Journal of Medicine 2010;4:259-64.
17)Idomir ME, Cocuz ME, Cheşca A,
Nemet CG. Analysis of results and optimization of a WEB-based program used for
the antibiotic resistance surveillance in a Romanian universitary hospital.
International Conference on Mathematical and Computational Methods in Science
and Engineering - Proceedings 2010;. 215-220
18) Varshochi M, Majidi J, Amini M, Ghabili K, Shoja MM. False positive seroreactivity
to brucellosis in tuberculosis patients: a prevalence study. International
Journal of General Medicine 2011 Mar 14;4:207-10.
19)Eshwarappa M, Dosegowda R, Aprameya
IV, Khan MW, Kumar PS, Kempegowda P. Clinico-microbiological profile
of urinary tract infection in South India. Indian Journal of Nephrology 2011;21:30-36.
20)Tsagarakis NJ et al. Flow cytometry
as a diagnostic tool in the early diagnosis of aggressive lymphomas mimicking
life-threatening infection. Case Reports in Medicine 2011;2011:743817.
21) de Vasconcelos-Pereira, E.F. , de
Matos, V.T.G. , Toffoli-Kadri, M.C. Intravenous
antibacterial use in an university medical centre, campo Grande, Mato Grosso do
sul, Brazil. International Journal of Pharmaceutical Sciences Review and Research 2011;8:1-5.
22) Tekiner A, Kocak Tufan Z, Bayar
MA, Tascioglu T, Erkoc YS, Hatipoglu C. Nosocomial Providencia stuartii
Meningitis: A Case Report Journal of Neurology Research Volume 1, Number 1, Apr
2011;1: 37-39.
23)Ali-Eldin FA, Abdelhakam SM,
Ali-Eldin ZA. Clinical spectrum of fever of unknown origin among adult Egyptian
patients admitted to Ain Shams University Hospitals: a hospital based study. J
Egypt Soc Parasitol. 2011 Aug;41(2):379-86.
24)Qin S, Yuan S-H, Hua X. Development of microdialysis in studying
the pharmacokinetics of quinolones in the brain. Chinese Pharmaceutical Journal
2011;46:1089-91.
25)Çamözü E, Kitiş Y. Determination of hospital cleaning staff's
knowledge and applications about collecting, transferring and stocking of
medical wastes. TAF Preventive Medicine Bulletin 2011;10:631-40.
26) Yamamoto A.Extended-spectrum
(ß-lactamase (ESBL)-producing Escherichia coli is frequently detected as a
pathogen of urinary tract infection in nursing home residents. Japanese Journal of Geriatrics 2011; 48:30-538.
27)Nicolle, L.E. Antimicrobial resistance. European Infectious
Disease 2011;5:92-97.
28) Naber KG, Thomas P, Fünfstück R.
Fosfomycin Trometamol in Patients with Renal Insufficiency and in the Elderly.
The International Arabic Journal of Antimicrobial Agents 2012;2:1-10.
29) Sarkar S. Continuing Medical
Education and the Hidden Curriculum: A Commentary on Bansal’s “The Patient is
Dead: Continuing Medical Education and the Hidden Curriculum”." International
Journal of User Driven Healthcare 2012;2: 94-96.
30) Unal S. The role of infectious
disease consultants: The Turkish experience
( Editorial ) Infectious Diseases in Clinical Practice 2012;20:99.
31) Devrim I, Gülfidan G, Oruç Y,
Yaşar N, Sorguç Y, Ayhan FY, Bayram N, Ünal N.
Point-prevalence study relating to antibiotic usage in Dr. Behçet Uz
children hospital; comparison of 2008 and 2012 data.
Journal of Pediatric infection. 2012; 6: 46-49.
32)Parlakay AO, Abdulmumin AH, Kara A,
Cengiz AB, Ince E, Çiftçi E, Tezer H, Özdemir H, Çeliker E. Prior to influenza
pandemics 2009 evaluation of views of health care staff Journal of Pediatric
infection 2012;6 :37-39
33)Watkins RR, Lemonovich TL, File TM
Jr. An evidence-based review of linezolid for the treatment of
methicillin-resistant Staphylococcus aureus (MRSA): place in therapy. Core
Evidence. 2012;7:131-43.
34) Güçlü E ve ark. Efficacy of
Education and Dissemination of Alcohol-Based Hand Antiseptics in the Hospital
in Improving Hand Hygiene Compliance. Flora 2012; 17:117-25.
35) Gençalioğlu AE ve ark. A Case of
Rhizobium radiobacter (Agrobacterium tumefaciens)-Related Bacteremia After
Percutaneous Biliary Drainage Catheterization. Flora 2012; 17:8286.
36) Gözel MG ve ark. Antimicrobial
Susceptibility and Frequency of Extended Spectrum Beta-Lactamase (ESBL) of
Escherichia coli Strains Isolated from Community Acquired and Nosocomial
Infections. Flora 2012;17:75-81.
37) Picazo JJ et al. Survey of Adult
Influenza and Pneumococcal Vaccination in Spain. Vacunas 2012; 13: 100-11.
38) Aydın M, Adıyaman G, Doğruman-Al
F, Kuştimur S, Ozkan S. [Determination of anti-echinococcus IgG antibodies by
ELISA in patients with suspected hydatid cyst]. Turkiye Parazitol Derg.
2012;36(2):61-4.
39) Polanco N et al. Differentiation
by +HRMN spectroscopy of Klebsiella pneumoniae, Staphylococcus aureus y
Streptococcus agalactiae in culture. Academia Biomedica Digital 2012:50.
40) Fünfstück R et al.
Fosfomycin-Trometamol- A useful therapeutic option for patients with urinary tract
infections. Nieren- und Hochdruckkrankheiten 2012;41: 375-384.
41) Fünfstück R et al.
Fosfomycin-Trometamol- A useful therapeutic option for patients with urinary
tract infections. Nieren- und Hochdruckkrankheiten 2012;41: 375-384.
42) Owusu M, Nguah SB, Boaitey YA et
al. Aetiological agents of cerebrospinal meningitis: a retrospective study from
a teaching hospital in Ghana. Ann Clin Microbiol Antimicrob. 2012 Oct 4;11:28.
43) Görkem M et al. Splenectomy in
haematological diseases; single center experience. J. Exp. Clin. Med., 2012; 29: 276-279.
44) Sentürk A et al. [Importance of
polymerase chain reaction in patients with histopathological diagnosis of
granulomatous disease by EBUS-TBNA: a preliminary report]. Tuberk Toraks. 2012
Dec;60(4):355-64.
45) Diktaş H, Hatipoğlu H, Turhan V et
al. Retrospective Evaluation of Cases with the Diagnosis of Acute Bacterial
Meningitis Over a 33-Year Period . Flora 2012;17:161-166
46) Nicolle LE. Issues in the
Diagnosis and Management of Urinary Tract Infections in the Older Adult. Current Translational Geriatrics and
Experimental Gerontology Reports. 2013;2: 136-42.
47)Doichinova TG et al. Otogenic meningoencephalitis caused by
Streptococcus pneumoniae. Journal of
Microbiology and Infectious Diseases. 2013; 3:86-88.
48) Bayram N et al. Evaluation of the
Factors Affecting the Attitudes of the Parents Towards to Use of Antibiotics.
Journal of Pediatric infection. 2013; 7: 57-60.
49) Babamahmoodi F et al.
Epidemiologic Characteristics of Patients Treated in a Referral Center With the
Diagnosis of Central Nervous System Infection in North of Iran, from March 2008
to March 2012: A Retrospective Observational Registry Study. Archives of
Neurosciences Archives of Neuroscience. 2013 October; 1(2): 82-87.
50) Behl R. The Economic and Clinical
Implications of Antibiotic Resistance. Berkeley Scientific Journal,
2013;17(2):1-6.
51) Jawień M, Garlicki AM.
Bacterial meningitis, principles of antimicrobial treatment. Przegląd
Epidemiologiczny, 2013;67, 421-427.
52) Sayın S et al. Isolated unilateral
inguinal tuberculous lymphadenitis: case report. Türk Hijyen ve Deneysel
Biyoloji Dergisi 2013; 70(2): 71 - 74.
53) Alavi SM et al. Changing pattern
of infectious etiology of fever of unknown origin (FUO) in adult patients in
Ahvaz, Iran. Caspian Journal of Internal Medicine, 2013;4(3):722,
54) Işıkay S, Yilmaz K. Acute
bacterial meningitis in childhood: analysis of 20 cases. Gaziantep Med J. 2013;
19(2): 93-98.
55) Ulu-Kilic A, Metan G, Alp E. Clinical
presentations and diagnosis of brucellosis. Recent Pat Antiinfect Drug Discov.
2013 Apr;8(1):34-41.
56) Al-Tawfiq JA, Memish ZA.
Antibiotic susceptibility and treatment of brucellosis. Recent Pat Antiinfect
Drug Discov. 2013 Apr;8(1):51-4.
57) Al-Tawfiq JA, Memish ZA.
Antibiotic susceptibility and treatment of brucellosis. Recent Pat Antiinfect
Drug Discov. 2013 Apr;8(1):51-4.
58) Munckhof WJ, Jennison AV, Bates
JR, Gassiep I. First report of probable neurobrucellosis in Australia. Med J
Aust. 2013 Sep 16;199(6):423-5.
59) Aydin M et al. The Role of
Cellular Prion Proteins (PrPC) on Microglial Brucella Infections. Agriculture,
Food and Analytical Bacteriology. 2013;3:268-80.
60) Cherwonogrodzky JW. Medical
Countermeasures, Protection and Treatment, against the Brucella species.
Journal of Bioterrorism & Biodefense 2013;s3:12.
61) Lafaurie M et al. Duration of
treatment of urinary tract infections. 2013;15:118-32.
62) Geçit İ et al. The Bacteria
Isolated From the Urine Cultures of Patients Admitted To Düzce Atatürk State
Hospital Urology Outpatient Clinic and Their Antibiotic Resistances. Konuralp
Tıp Dergisi 2013;5(3):34-37.
63) Baricot M et al. A study of
attitudes and knowledge of influenza vaccination in primary care health
professionals. Season 2011-2012Vacunas. 2013; 14:22-29.
64) Xie F et al. Proteomic analysis of
Bacillus subtilis 168 transforming cis-propenylphosphonic acid to fosfomycin.Shengwu Gongcheng Xuebao/Chinese Journal of
Biotechnology 2013;29:735-750.
65) Hof H. Chemotherapy of Listeria
infections. GMS Infect Dis 2013;1:Doc06
61) Alici H et al. Brucella infective
endocarditis. Cor et Vasa. 2014;56: e433–e435.
62)Munoz-Davila MJ. Role of Old
Antibiotics in the Era of Antibiotic Resistance. Highlighted Nitrofurantoin for
the Treatment of Lower Urinary Tract Infections. Antibiotics. 2014; 3(1):39-48.
63)Creighton JA. Susceptibility
testing of extended-spectrum-beta-lactamase (ESBL) - producing
Enterobacteriaceae against oral antimicrobials, including fosfomycin and
mecillinam [online]. New Zealand Journal of Medical
Laboratory Science, 2014; 68: 19-23.
64)Dinaker M et al..
A Case of Cavernous Sinus Thrombosis with Meningitis Caused by Community
Acquired Methicillin Resistant Staphylococcus Aureus. Journal Of The
Assocıatıon Of Physıcıans Of Indıa, 2014, 62: 65.
65) Ikhlas A et al..
Fever of unknown origin in children: A challenge persisting with advancing
medical care. Journal of Pediatric Infectious Diseases, 2014;9: 19-22.
66)Sevgi DY et al. Ertapenem for the
treatment of complicated urinary tract infections caused by extended-spectrum
β-lactamase-producing bacteria: a case series report. Dis Mol Med. 2014;
2(1): 7-11.
67)Karadağ A et al. In vitro efficacy
of fosfomycin against clinical strains. Journal of Microbiology and Infectious
Diseases 2014;4: 55-58.
68)Jeroense KTV et al. Case Report
One-stage revision in two cases of Salmonella prosthetic hip infection. World
Journal of Clinical Cases ESPS Manuscript NO: 8513 Columns:
69)Fair RJ et al .
Yitzhak. Antibiotics and Bacterial Resistance in the 21st Century. Perspectives
in medicinal chemistry, 2014;6: 25.
70)Frey KG et al Full-Genome Assembly
of ReferenceStrain Providencia stuartii ATCC 33672. Genome Announc. 2014 Oct
23;2(5). pii:e01082-14. doi: 10.1128/genomeA.01082-14.
71)Garapati S, Peethala S. Assessment
of knowledge and practices on injection safety among service providers in east
Godavari district of Andhra Pradesh. Indian Journal of Community Health, 2014,;26.: 259-263.
72)Song S, Kim C, Lim D. Clinical Efficacy of Ertapenem for Recurrent
Cystitis Caused by Multidrug-Resistant Extended-Spectrum
β-Lactamase-Producing Escherichia coli in Female Outpatients. Korean J Urol. 2014 Apr;55(4):270-275.
73)Song S, Kim C, Lim D. Clinical Efficacy of Ertapenem for Recurrent
Cystitis Caused by Multidrug-Resistant Extended-Spectrum
β-Lactamase-Producing Escherichia coli in Female Outpatients. Korean J Urol. 2014 Apr;55(4):270-275.
74) Beyhun NE et al. Willingness to
Receive the Influenza A (H1N1) Vaccine and its Determinants among University
Students during the 2009 Outbreak in Turkey. Eurasian J Med. 2014 Feb; 46(1):
8–14.
75)Özvatan T et al. Gluteal Abscess in
Immunosuppressed Patient Caused by Salmonella Enteritidis Uludağ Üniversitesi
Tıp Fakültesi Dergisi
2014;40:85-87
76) Sultan A et al. Increasing
antimicrobial resistance among uropathogens: Is fosfomycin the answer?. Urology annals, 2015, 7.1: 26.
Ulusal dergilerdeki atıflar/Citations in national journals
1) Karadağ F, Hariri AG, Kenar J.
Awareness of Sexually Transmitted Diseases and Risky Sexual Behavior Amongst
Patients with Schizophrenia and Bipolar Mood Disorder. Klinik Psikiyatri
Dergisi 2004;7(1):17-25
2)Hariri AG, Karadağ F, Aksoy M. The
level of awareness on sexually transmitted diseases of patients with bipolar
mood disorder and patients with heroine dependence. Anadolu Psikiyatri Dergisi
2004;5(2):107-113
3) Gülhan B, Özekinci T, Atmaca S.
Antibiotic Resistance in Escherichia coli Strains with Ten Years Interval
(1996-2006). Ankem Dergisi 2006;20:226-228.
4) Saçar S, Kavas Toprak S, Asan A,
Hırçın Çenger D, Turgut H. Point Prevalence Study Relating to Antibiotic Usage
in Pamukkale University Hospital. Ankem Dergisi 2006;20:217-221
5) Arslan H. Toplum Kökenli
infeksiyonların Sağaltımına Akılcı Yaklaşımlar: üriner Sistem infeksiyonları
Klimik Dergisi 2007; 20 s1: 86-90
6) Koçoğlu S, Karabay O, İnce NK,
Özkardeş F, Yıldırım R. The Frequency of Extended Spectrum Beta-lactamase
Production and Antibiotic Susceptibility of Escherichia coli Strains Isolated
from Community-acquired Urinary Tract Infections. Ankem Dergisi 2007; 21:5-9
7) Gazi H, Sürücüoğlu S, Kurutepe S.
Antimicrobial Resistance of Gram Negative Bacteria Isolated from Urine
Cultures. Ankem Dergisi 2007;21: 19-22.
8) Mulazimogullari L Antibiyotik
kullanım politikaları. Klimik Dergisi 2007;20 s2: 12-13
9)Kaşifoğlu N, Kiremitçi A, Durmaz G,
Akgün Y, Çetin E
Bacteria isolated from urine samples in microbiology laboratory
of ESOGU hospital and and antimicrobial susceptibility: 2002-2005 data.
Osmangazi Tıp Dergisi 2007; 29:69-75
10) Palanduz A, Telhan L, Öztürk AO
Diagnosis of Influenza by a Rapid Test in the Outpatient Department of
Pediatrics. Journal of Pediatric Infection 2007; 1: 13-6
11)Avcı M, Özgenç O, Coşkuner A,
Mermut G, Arı A Nosocomial Infectious Agents in Intensive Care Unit and Yearly
Variations of Antibiotic Resistance Profile in the most Frequently Isolated
Microorganisms Ankem Dergisi 2007;21:179-183
12)Kayman T, Ayangil D. Antimicrobial
Susceptibility of Enterobacteriaceae Strains Isolated in Kayseri Educational
and Research Hospital. ANKEM Dergisi 2007;21(4):203-207
13) Göker G, Kaya I
, Aydın K, Gürler N. Investigation of Escherichia coli, Klebsiella and
Enterococcus spp. Susceptibilities to Fosfomycin Tromethamole in Urinary Tract
Infections. ANKEM Dergisi 2007;21(4):219-222
14)Yenice İ, Ünal S. On yılın verileri
ışığında teikoplanin Flora 2007; 12 supp 3:3-40
15) Dizbay M, Çağlar Ö, Arman D. In
Vitro Synergistic Effect of Cefoperazone-sulbactam and Netilmicin Combination
in Multidrug Resistant Acinetobacter baumannii Strains Isolated from Ventilator
Associated Pneumonia. Ankem Dergisi 2008;22:28-31.
16)Esen Ş. ESBL and IBL Producing
Bacteria: Clinical Importance and Treatment. Ankem Dergisi 2008;22:27-35
17)Leblebicioglu H Çoğul dirençli gram
negatif bakterilerin kontrolü: antibiyotik yonetim programlarının etkisi.
Hastane Infeksiyonlari Dergisi 2008;12:65-69
18)Kurtaran B, Oto OA, Candevir A,
Saltoglu N, Aksu HSZ. "Pan"dora's box: a case of polyarteritis nodosa
with fever of unknown origin. Flora 2008; 13;47-51.
19)Güzel-Tunçcan Ö, Keten-Tozlu D,
Dizbay M, Hızel K. Antimicrobial Susceptibility of Ertapenem Comparing with
other Antibiotics against Nosocomial Escherichia coli and Klebsiella Strains.
ANKEM Dergisi 2008;22(4):188-192
20) Kelebek-Girgin N, Yılmaz E,
Kuruefe NR, Kahveci F, Akalın H, Özcan B. Fatal pneumococcal purpura fulminans
in an asplenic patient. Klimik Dergisi 2008; 21:69-71.
21)Dundar D, Willke A, Sonmez-Tamer G. Causative agents
of urinary tract infections and their antimicrobial susceptibilities. Klimik
Dergisi 2008;21:7-11.
22)Temiz H, Akkoc H, Gul K. Antibiotic
Resistance of Gram Negative Bacteria Isolated From Urine Cultures in Our
Laboratory. Dicle Tıp Dergisi, 2008;35:4:234-239.
23)Dundar D, Sonmez-Tamer G. Antimicrobial
Susceptibilities of Staphylococcus aureus Strains Isolated from Clinical
Samples: Three Years Evaluation ANKEM Dergisi 2009;23(1):8-12.
24) Devrim İ, Gülfidan G, Tavli V,
Dizdarer C, Yasar N, Oruc Y, Sorguc Y, Ayhan FY. Point-Prevalence Study
Relating to Antibiotic Usage in Dr. Behcet Uz Children Hospital
Point-Prevelance Study for Antibiotics. Journal of Pediatric Infection 2009; 3:
11-3.
25) Akalin H. Decreasing and
Prevention of Antibiotic Resistance in the Intensive Care Unit. ANKEM Dergisi
2009;23(Ek 2):157-161.
26) Akalin H. Decreasing and
Prevention of Antibiotic Resistance in the Intensive Care Unit. ANKEM Dergisi
2009;23(Ek 2):157-161.
27)Pullukçu H. Hastane personelinin
nosokomyal infeksiyonlardan korunması. Sağlıkta Birikim 2009;1:58-64.
28) Bilgi O, Karagöz B, SÜcüllü İ,
Filiz Aİ, Kandemir EG. Colonic Adenocarcinoma Presenting with Fever of Unknown
Origin. Kolon ve Rektum Hastalıkları Dergisi 2009;19:39-43.
29)Kelebek-Girgin N, Yılmaz E, Kuruefe
NR, Kahveci F, Akalın H, Özcan B. Fatal pneumococcal purpura fulminans in an
asplenic patient. Klimik Dergisi 2008;21:69-71.
30) Nayman Alpat S, Ünlü F, Erben N,
Doyuk-Kartal E, Özgüneş İ, Ulsluer G Etiology of fever of unknown origin in
Eskisehir. Flora 2009; 14:67-71.
31)Nazik H, Öngen B, Emiroğlu HH,Turan D, İlktac M, Gürler N, Ayan İ. Shigella sonnei
Bacteremia in an Immunosuppressed Child: A Case Report ANKEM Dergisi
2009;23(3):133-136.
32) Albayrak N, Kaya Ş. Extended
spectrum beta-lactamases production and antimicrobial resistance ratio of the
Escherichia coli and Klebsiella pneumoniae strains isolated from various
clinical specimens. Türk Mikrobiyoloji Cemiyeti Dergisi 2009;39 (1-2): 16-21.
33) Arman D, Sarı N, Ergüt Sezer B,
Ata N, Dizbay M, Hızel K, İleri F, Ulutan F. A case o methicillin-sensitive
Staphylococcus aureus (MSSA) meningitis-cerebritis treated with linezolid.
Flora 2009;14:139-143.
34) Uyanık MH, Hancı H, Yazgı H.
Activity of Fosfomycin Trometamol and some other Antibiotics to Escherichia
coli Strains Isolated from Community-acquired Urinary Tract Infections. ANKEM
Dergisi2009;23(4):172-176
35) Üstün C, Demir YS, Demir S,
Demirören S, Kurtoğlu MG. In-vitro Antibacterial Resistance Rates among
Escherichia coli and Klebsiella spp. Strains Isolated from Community-acquired
Pediatric Urinary Tract Infections. ANKEM Dergisi 2009;23(4):155-160.
36) Zorlu S, Akalın H, Yılmaz E, Heper
Y, Mıstık R, Helvacı S. Fever of unknown origin: retrospective analysis of 38
cases. Flora 2009;14:159-64.
37) Tuncer I, Kalem F, Coşar M, Arslan
U. Antibiotic susceptibility of Staphylococcus aureus strains isolated from
bloodstream infections. Türk Mikrobiyoloji Cemiyeti Dergisi 2009;39:22-26.
38) Dikici N, Korkmaz F, Dağlı Ş, Genç
Ö, Ural G. Nosocomial infections in intensive care units, Konya Numune Hospital,
Three year experience. Turkish Journal of Infection 2009; 23 (4): 163-167
39) Arda B. Case of
Multidrug-resistant Acinetobacter baumannii. ANKEM Dergisi 2010;24(Ek 2):78-81.
40) Şerefhanoğlu K, Ergin-Timurkaynak
F, Arslan H. Device-asscociated nosocomial infections in the general
intensive-care unit of BAskent University İstanbul Research and Education
Center. Flora 2010;15:16-23.
41) Ramazanzadeh R Etiologic agents
and extended-spectrum beta-lactamase production in urinary tract infections in
Sanandaj, Iran Eastern Journal of Medicine 2010;15: 57-62.
42) Yaman G, Cikman A, Berktas M,
Parlak M, Güdücüoğlu H, Karahocagil MK. The MLSB, Fusidic Acid and Various
Antibiotic Resistance Rates of Nosocomial Staphylococcus aureus Isolates. ANKEM
Dergisi 2010;24(3):130-135
43) Akbayrak N, Başçivan G Evidence
Based Practice For Preventing Infection that Frequently Encountered in the
Intensive Care Unit. Journal of Anatolia Nursing and Health Sciences 2010;13:65-71.
44) Demiraslan H, Aktuğ Demir N,
Kölgelier S. Rate of Extended-spectrum Beta-lactamase produciton in
Enterobacteriaceae and their antibiotic susceptibility against various
antibiotics in Adıyaman. Flora 2010; 15:112-117.
45) Arda B. Treatment and Management
of Infections Caused by Resistant Non-fermentative Gram-negative Bacteria.
Ankem Dergisi 2011;25:(Supp 2):45-9.
46) Karabay O. Infectious Disease
Specialist Approved Antibiotic Usage Contribution on the Quality. Ankem Dergisi
2011;25:(Supp 2):119-22.
47) Isikgoz-Tasbakan M.
Hospital-acquired Pneumonia Prevention. Ankem Dergisi 2011;25:(Supp 2):28-31.
48) Erbay-Apaydın F, Orhan B, Bilgi S,
Akalın S. Use of Posaconazole for Pulmonary Mucormycosis in Persistent Febrile
Neutropenia: A Case Report. Klimik Dergisi 2011; 24(1): 57-61
49) Akalin H Antimicrobial Resistance
and Prevention Policies. ANKEM Dergisi 2011;25(3):190-195.
50) Vural A, Afşar İ, Kurultay N,
Demirci M. Comparison of Disk Diffusion, Oxacillin Agar Screening,
Microdilution and PBP2a Latex Agglutination Tests for Detection of Methicillin
Resistance in Staphylococcus aureus. ANKEM Dergisi 2011;25(3):145-149.
51)Bayram Y, ERen H, Berktaş M.
Distribution of bacterial pathogens in urine samples and resistance patterns of
ESBL positive and negative Escherichia coli isolates against fosfomycin and
other antimicrobials. Ankem Dergisi 2011;25:232-36.
52) Cesur S, Altın N, Toros-Yapar G ve
ark. Intrathecal Netilmycin Treatment in
a Case with Post-neurosurgical Nosocomial Meningitis. due to Multidrug
Resistant Acinetobacter baumannii. Türk Mikrobiyoloji Cemiyeti Dergisi 2011;
41(4):168-171.
53) Paketçi C, Sezer RG, Paketçi A ve ark.
Zeynep Kamil Tıp Bülteni 2012;43:26-31
54)Pullukcu H. Complicated Urinary
Tract Infections and Guides. Ankem Dergisi 2012; 26 (supp2):163-68.
55)Pullukcu H. Complicated Urinary
Tract Infections and Guides. Ankem Dergisi 2012; 26 (supp2):163-68.
56)Pullukcu H. Complicated Urinary
Tract Infections and Guides. Ankem Dergisi 2012; 26 (supp2):163-68.
57) Pullukcu H. Complicated Urinary
Tract Infections and Guides. Ankem Dergisi 2012; 26 (supp2):163-68.
58) Pullukcu H. Complicated Urinary
Tract Infections and Guides. Ankem Dergisi 2012; 26 (supp2):163-68.
59) Parlak M ve ark. Salmonella and
Shigella Strains Isolated from Blood and Stool Samples and their Antibiotic
Resistance Rates. Ankem Dergisi 2012; 26(3):126-130.
60) Köksaldı-motor V ve ark. The
Evaluation of Health-care Associated Infections in Intensive Care Unit of
Mustafa Kemal University Medical School in 2011. ANKEM Dergisi
2012;26(3):137-142.
61) Karaayak-Uzun B ve ark. The
Frequency of Extended-spectrum Beta-lactamases and In-vitro Antibiotic
Resistance. Ankem Dergisi 2012;26(4):181-186.
62) Tekin A. In Vitro Effectiveness of
Fosfomycin and some Antibiotics for Uropathogenic Escherichia coli Isolates.
ANKEM Dergisi 2012;26(2):61-68.
63) Tekin A. In Vitro Effectiveness of
Fosfomycin and some Antibiotics for Uropathogenic Escherichia coli Isolates.
ANKEM Dergisi 2012;26(2):61-68.
64) Gülmez D ve ark. Experiences of a
University Hospital Participating in the National Enteric Pathogens
Surveillance Network (UEPLA): Four- year data of
Salmonella, Shigella and Campylobacter. Türk Mikrobiyol Cem Derg
2012;42(3):85-92,
65) Eser O, Aycicek A, Tokyol Ç,
Karavelioglu E, Yildizhan S. Cervical tuberculosis lymphadenitis:Case
report. Gümüşhane University Journal of Health Sciences. 2012;1:120-26.
66) Atalan N ve ark. Evalution of
Nosocomial Infections and Antibiotic Resistance Profiles in Intensive Care
Unit. GKDA Dergisi 2012; 18(2):46-51.
67) Karaoğlan İ. Classification and
Etiology of Skin and Soft Tissue Infections. Yoğun Bakım Dergisi
2012;10(3):109-119.
68) Kuşcu F et al. Hydatid Cyst
Disease of the Spine:Evaluation of Seven Cases.
Mediterr J Infect Microb Antimicrob 2013;2:9.
69) Arman D. Rational Antibiotic Use
in Hospital-acquired Infections ANKEM Derg 2013;27(Ek 2):113-11.
70) Arman D. Rational Antibiotic Use
in Hospital-acquired Infections ANKEM Derg 2013;27(Ek 2):113-11.
71) Soylu GG et al. Investigation of
Antibiotic Susceptibilities and Pulsed Field Gel Electrophoresis Genotypic
Profiles of Shigella Strains Produced from Clinical Specimens. ANKEM Derg 2013;27:113-123.
72) Şentirk-Köksal et al. Bacteria
Isolated From Community AcquiredUrinary Tract Infectionsof Pediatric
Patientsand TheirAntibiotic Susceptibility. Inönü Üniversitesi Sağlık Bilimleri
Dergisi 2013; 2:1-4
73) Taşbakan MI. Urinary Tract
Infections and Rational Use of Antibiotics. ANKEM Derg 2014;28(Ek 2):178-181.
74) Taşbakan MI. Urinary Tract
Infections and Rational Use of Antibiotics. ANKEM Derg 2014;28(Ek 2):178-181.
75) Taşbakan MI. Urinary Tract
Infections and Rational Use of Antibiotics. ANKEM Derg 2014;28(Ek 2):178-181.
76) Taşbakan MI. Urinary Tract
Infections and Rational Use of Antibiotics. ANKEM Derg 2014;28(Ek 2):178-181.
77) Taşbakan MI. Urinary Tract
Infections and Rational Use of Antibiotics. ANKEM Derg 2014;28(Ek 2):178-181.
78) Taşbakan MI. Urinary Tract
Infections and Rational Use of Antibiotics. ANKEM Derg 2014;28(Ek 2):178-181.
79) Tezcan K, Tamer A. Nedeni
Bilinmeyen Ateş. Sakarya Medical Journal 2014;4(2):104-108.
80) Sirmatel F et al "Diyabetes
Mellitusda Kriptokok ve Mukor ile Birlikte Görülen Bir Rhino-Orbital Mukormikoz
Olgusu." Mersin Üniversitesi Sağlık Bilimleri Dergisi 2013;6:21-25.
81) Kurt Ö et al. Toplumsal kaynakli
üriner sistem infeksiyonlarindan izole edilen escherichia coli suşlarinda
fosfomisin, nitrofurantoin ve siprofloksasinin in-vitro etkinliği. ANKEM Derg,
2014,;28: 58-62.
82) Kurt Ö et al. Toplumsal kaynakli
üriner sistem infeksiyonlarindan izole edilen escherichia coli suşlarinda
fosfomisin, nitrofurantoin ve siprofloksasinin in-vitro etkinliği ANKEM Derg,
2014;28: 58-62
83) Kurt Ö et al. Toplumsal kaynakli
üriner sistem infeksiyonlarindan izole edilen escherichia coli suşlarinda
fosfomisin, nitrofurantoin ve siprofloksasinin in-vitro etkinliği. ANKEM Derg,
2014;28: 58-62
84) Arslan FT, Aldem M. [Applications
of Midwives and Nurses Working at Pediatrics Clinics to Patients Security]. TAF
Prev Med Bull. 2014; 13(3): 209-216. Turkish.
85) Demir NA et al. AtypicalA
cinetobacter baumannii Meningitis: Case Report. Mediterr J Infect Microb
Antimicrob 2014;3:6.
86) Demir NA et al. Atypical
Acinetobacter baumannii Meningitis: Case Report. Mediterr J Infect Microb
Antimicrob 2014;3:6
Last updated 8 March 2016
Main page/Ana sayfa, AIDS,
hepatitis, substance abuse/AIDS; hepatit, madde bağımlılığı, GöztepeLIST, Quatrains from Omar Hayyam/Ömer Hayyam'dan seçtiklerim, Poems from Ataol Behramoğlu /Ataol Behramoğlu'ndan seçtiklerim,
Epigrams/Özlü sözler , Atatürk'ten yöneticilere öğütler , Jokes/Fıkralar,
Classical
music/Klasik müzik, Curriculum vitae/yaşam hikayem, Personal interests/Kişisel ilgi alanlarim, Links/Linkler, Ege
Üniversitesi İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji AD, Links/Linkler, Best tourist guides in Ephesus
